STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

SUSAN G KOMEN BREAST CANCER FOUNDATION: Form 990, tax year 2018

View the entire original 990 at ProPublica ↗

Organization
SUSAN G KOMEN BREAST CANCER FOUNDATION (EIN 75-1835298)
Tax period
2018-04-01 to 2019-03-31
Filed
2019-11-26
IRS object ID
201903309349300435
Schema version
2018v3.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2019-11-26T20:29:23-06:00ReturnTs
Tax Period End2019-03-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1ERNST & YOUNG US LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line11901 6TH AVE NAddressLine1Txt
CityBIRMINGHAMCityNm
State AbbreviationALStateAbbreviationCd
ZIP35203ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2018-04-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN751835298EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1SUSAN G KOMEN BREAST CANCER FDN INCBusinessNameLine1Txt
FieldValueIRS element (for citing)
In Care Of% Ria WilliamsInCareOfNm
Business Name ControlSUSABusinessNameControlTxt
Phone9728551600PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line15005 LBJ Freeway Suite 526AddressLine1Txt
CityDallasCityNm
State AbbreviationTXStateAbbreviationCd
ZIP752446125ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonPaula Sue SchneiderPersonNm
Person TitlePresident and CEOPersonTitleTxt
Phone9728551600PhoneNum
Signature2019-11-22SignatureDt

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonKATHY PITTSPreparerPersonNm
PTINP00292940PTIN
Phone2052260027PhoneNum
Preparation2019-11-15PreparationDt

Filing Security Information FilingSecurityInformation

IP Address IPAddress

FieldValueIRS element (for citing)
I Pv4 Address181.229.5.177IPv4AddressTxt
FieldValueIRS element (for citing)
Federal Original Submission Id75306120193305000000FederalOriginalSubmissionId
Federal Original Submission Id2019-11-26FederalOriginalSubmissionIdDt
Filing License TypePFilingLicenseTypeCd
At Submission Creation Device IdD7645E384763AEB8339B885771554B833BC3ADBEAtSubmissionCreationDeviceId
At Submission Filing Device IdE29A02FADCAF5825D1E75B57BBFB9CE762992CE9AtSubmissionFilingDeviceId
FieldValueIRS element (for citing)
Tax2018TaxYr
Build TS2020-03-31 21:24:44ZBuildTS

Form 990 IRS990

Doing Business As Name DoingBusinessAsName

FieldValueIRS element (for citing)
Business Name Line1SUSAN G KOMENBusinessNameLine1Txt
FieldValueIRS element (for citing)
Principal OfficerPaula Sue SchneiderPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line15005 LBJ Freeway Suite 526AddressLine1Txt
CityDallasCityNm
State AbbreviationTXStateAbbreviationCd
ZIP752446125ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$138,576,137GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
Group Exemption7164GroupExemptionNum
Organization501c3Yes (X)Organization501c3Ind
Website Addresswww.komen.orgWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1982FormationYr
Legal Domicile StateTXLegalDomicileStateCd
Activity Or MissionSUSAN G. KOMENFIGHTS BREAST CANCER ON ALL FRONTS BY DRIVING RSRCH,ADVOCATING FOR COMPASSIONATE PUBLIC POLICIES, PROVIDING TRUSTWORTHY INFO & SUPPORT PEOPLE FACING BREAST CANCER TODAYActivityOrMissionDesc
Voting Members Governing Body13VotingMembersGoverningBodyCnt
Voting Members Independent13VotingMembersIndependentCnt
Total Employee248TotalEmployeeCnt
Total Volunteers2600TotalVolunteersCnt
Total Gross UBI$60,395TotalGrossUBIAmt
PY Contributions Grants$51,441,732PYContributionsGrantsAmt
CY Contributions Grants$63,291,987CYContributionsGrantsAmt
PY Program Service Revenue$14,437,717PYProgramServiceRevenueAmt
CY Program Service Revenue$12,975,072CYProgramServiceRevenueAmt
PY Investment Income$14,239,081PYInvestmentIncomeAmt
CY Investment Income$15,415,716CYInvestmentIncomeAmt
PY Other Revenue-$3,380,561PYOtherRevenueAmt
CY Other Revenue-$1,624,976CYOtherRevenueAmt
PY Total Revenue$76,737,969PYTotalRevenueAmt
CY Total Revenue$90,057,799CYTotalRevenueAmt
PY Grants And Similar Paid$28,995,790PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$29,481,585CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$21,442,628PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$22,862,266CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$1,118,493PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$2,527,973CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$13,711,290CYTotalFundraisingExpenseAmt
PY Other Expenses$31,719,529PYOtherExpensesAmt
CY Other Expenses$37,154,373CYOtherExpensesAmt
PY Total Expenses$83,276,440PYTotalExpensesAmt
CY Total Expenses$92,026,197CYTotalExpensesAmt
PY Revenues Less Expenses-$6,538,471PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$1,968,398CYRevenuesLessExpensesAmt
Total Assets BOY$201,811,514TotalAssetsBOYAmt
Total Assets EOY$192,149,996TotalAssetsEOYAmt
Total Liabilities BOY$77,405,059TotalLiabilitiesBOYAmt
Total Liabilities EOY$75,529,111TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$124,406,455NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$116,620,885NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionSUSAN G. KOMEN IS FIGHTING BREAST CANCER ON ALL FRONTS BY DRIVING RESEARCH BREAKTHROUGHS, ADVOCATING FOR COMPASSIONATE PUBLIC POLICIES, DELIVERING TRUSTWORTHY INFORMATION, AND PROVIDING CRITICAL SUPPORT TO PEOPLE FACING BREAST CANCER TODAY, HELPING THEM LIVE LONGER, HEALTHIER LIVES.MissionDesc
Significant New Program SrvcfalseSignificantNewProgramSrvcInd
Significant ChangefalseSignificantChangeInd
Activity32ActivityCd
Expense$31,327,575ExpenseAmt
Grant$25,620,549GrantAmt
Revenue$12,446,089RevenueAmt
DescGRANTS TO RESEARCH INSTITUTIONS AND OTHER NONPROFIT ORGANIZATIONS TO SUPPORT BREAST CANCER RESEARCH PROJECTS INCLUDING THOSE FOCUSED ON THE BIOLOGY OF BREAST CANCER; EARLY DETECTION, DIAGNOSIS, AND PREVENTION STRATEGIES; DEVELOPING TARGETED THERAPIES, OVERCOMING BREAST CANCER PROGRESSION, TREATMENT RESISTANCE AND METASTASIS, PREDICTING RISK, DEVELOPING NEW IMAGING TECHNIQUES, AND UNDERSTANDING AND ADDRESSING DISPARITIES IN OUTCOMES AS WELL AS RESEARCH RESOURCES AND CONFERENCES. SEE SCHEDULE O FOR ADDITIONAL DETAILS.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Activity32ActivityCd
Expense$24,622,304ExpenseAmt
Grant$582,735GrantAmt
Revenue$875,657RevenueAmt
DescPROVISION OF BREAST HEALTH/CANCER EDUCATION RESOURCES & PATIENT SUPPORT PROGRAMS WERE MADE POSSIBLE DIRECTLY BY KOMEN AND THROUGH GRANTS TO OTHER NONPROFIT ORGANIZATIONS TO INCREASE THE PUBLIC'S KNOWLEDGE OF BREAST CANCER, ITS RISK FACTORS, THE IMPORTANCE OF EARLY DETECTION & SCREENING, KNOWING WHAT IS NORMAL FOR YOU, LIFESTYLE CHOICES, DIAGNOSIS AND TREATMENT, METASTATIC BREAST CANCER, CLINICAL TRIALS, SOCIAL SUPPORT, COMMUNICATION, COMPLEMENTARY AND INTEGRATIVE THERAPIES, AND COMMUNITY RESOURCES. SEE SCHEDULE O FOR ADDITIONAL DETAILS.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Activity32ActivityCd
Expense$5,143,857ExpenseAmt
Grant$3,278,301GrantAmt
Revenue$0RevenueAmt
DescGRANTS TO OTHER NONPROFIT ORGANIZATIONS TO SUPPORT BREAST CANCER SCREENING, DIAGNOSIS, AND TREATMENT PROGRAMS WITH A SPECIAL EMPHASIS ON PATIENT NAVIGATION, ESPECIALLY IN COMMUNITIES WHERE DISPARITIES IN OUTCOMES ARE SIGNIFICANT AND/OR ACCESS IS LIMITED. SEE SCHEDULE O FOR ADDITIONAL DETAILS.Desc
FieldValueIRS element (for citing)
Total Program Service Expenses$61,093,736TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredYes (true)ScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesYes (true)LobbyingActivitiesInd
Subject To Proxy TaxfalseSubjectToProxyTaxInd
Donor Advised FundfalseDonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtfalseCollectionsOfArtInd
Credit CounselingfalseCreditCounselingInd
Temp Or Permanent EndowmentsYes (true)TempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecYes (true)ReportInvestmentsOtherSecInd
Report Program Related InvstfalseReportProgramRelatedInvstInd
Report Other AssetsfalseReportOtherAssetsInd
Report Other LiabilitiesfalseReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (true)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtfalseIndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (true)ConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficefalseForeignOfficeInd
Foreign ActivitiesYes (true)ForeignActivitiesInd
More Than5000 K To OrgYes (true)MoreThan5000KToOrgInd
More Than5000 K To IndividualsfalseMoreThan5000KToIndividualsInd
Professional FundraisingYes (true)ProfessionalFundraisingInd
Fundraising ActivitiesYes (true)FundraisingActivitiesInd
Gaming ActivitiesfalseGamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsYes (true)GrantsToOrganizationsInd
Grants To IndividualsfalseGrantsToIndividualsInd
Schedule J RequiredYes (true)ScheduleJRequiredInd
Tax Exempt BondsfalseTaxExemptBondsInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingfalseLoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemfalseBusinessRlnWithFamMemInd
Business Rln With Officer EntfalseBusinessRlnWithOfficerEntInd
Deductible Non Cash ContriYes (true)DeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityfalseDisregardedEntityInd
Related EntityfalseRelatedEntityInd
Related Organization Ctrl EntfalseRelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgfalseTrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
IRP Document78IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (true)BackupWthldComplianceInd
Employee248EmployeeCnt
Employment Tax Returns FiledYes (true)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitYes (true)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (true)Form990TFiledInd
Foreign Financial AccountfalseForeignFinancialAccountInd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsfalseNondeductibleContributionsInd
Quid Pro Quo ContributionsYes (true)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (true)QuidProQuoContriDisclInd
Form8282 Property Disposed OffalseForm8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht PymtfalseSubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst IncfalseSubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members13GoverningBodyVotingMembersCnt
Independent Voting Member13IndependentVotingMemberCnt
Family Or Business RlnfalseFamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsfalseChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersfalseMembersOrStockholdersInd
Election Of Board MembersfalseElectionOfBoardMembersInd
Decisions Subject To ApprovafalseDecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (true)MinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersYes (true)LocalChaptersInd
Policies Reference ChaptersYes (true)PoliciesReferenceChaptersInd
Form990 Provided To Gvrn BodyYes (true)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOYes (true)CompensationProcessCEOInd
Compensation Process OtherYes (true)CompensationProcessOtherInd
Investment In Joint VenturefalseInvestmentInJointVentureInd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldDCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldHIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldINStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldUTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonRia WilliamsPersonNm
Phone9728551600PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line15005 LBJ Freeway Suite 526AddressLine1Txt
CityDallasCityNm
State AbbreviationTXStateAbbreviationCd
ZIP75244ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (36 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeIndFormer Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd
Peter D Brundage
Chair of Board (Beg. 6/18)1.00.0Yes (X)Yes (X)$0$0$0
Michael B GreenwaldBEG 618
BOARD MEMBER AND TREASURER1.00.0Yes (X)Yes (X)$0$0$0
Connie O'Neill BOARD MEMBER
FMR BOARD CHAIR (END 6/18)1.00.0Yes (X)$0$0$0
Linda Custard
BOARD MEMBER1.00.0Yes (X)$0$0$0
Meghan Shannon
BOARD MEMBER1.00.0Yes (X)$0$0$0
Trish Wheaton
BOARD MEMBER1.00.0Yes (X)$0$0$0
Angela Zepeda
BOARD MEMBER1.00.0Yes (X)$0$0$0
Kim Bohr
BOARD MEMBER1.00.0Yes (X)$0$0$0
Andrew Robinson
BOARD MEMBER1.00.0Yes (X)$0$0$0
Kaye Ceille
BOARD Member (BEG. 6/18)1.00.0Yes (X)$0$0$0
Doug Knutson MD
BOARD Member (BEG. 6/18)1.00.0Yes (X)$0$0$0
Kristin Nimsger
Board Member (Beg. 6/18)1.00.0Yes (X)$0$0$0
Stephanie Stahl
BOARD MEMBER (Beg. 6/18)1.00.0Yes (X)$0$0$0
Dan Glennon End 618
Board Member and Treasurer1.00.0Yes (X)Yes (X)$0$0$0
Jane Abraham
BOARD Member (End 6/18)1.00.0Yes (X)$0$0$0
Alan Feld
Board Member (End 6/18)1.00.0Yes (X)$0$0$0
Dr Olufunmilayo Olopade
Board Member (End 6/18)1.00.0Yes (X)$0$0$0
Janet Dunn Frantz
Board Member (End 6/18)1.00.0Yes (X)$0$0$0
Melissa Maxfield
Board Member (End 6/18)1.00.0Yes (X)$0$0$0
Paula Schneider
President and CEO55.00.0Yes (X)$552,025$0$7,081
Catherine Olivieri Beg 319
VP, HR and Corporate Secretary55.00.0Yes (X)$225,406$0$45,568
Dana Brown Beg 319
SVP CHIEF STRATEGY & OPS55.00.0Yes (X)$44,118$0$140
Ria Williams Beg 1018
Chief Financial Officer55.00.0Yes (X)$181,446$0$16,424
Robert Green End 1018
Chief Financial Officer55.00.0Yes (X)$309,315$0$13,027
Adam Vanek END 219
GEN. COUNSEL & CORPORATE SECY55.00.0Yes (X)$245,603$0$25,485
Christina Alford
SVP, Development55.00.0$287,093$0$23,635Yes (X)
Victoria Wolodzko
VP RESEARCH AND COM. HEALTH PR55.00.0$228,703$0$23,240Yes (X)
Lori Maris
SVP, Affiliate Network55.00.0$188,269$0$18,100Yes (X)
Eric Montgomery
VP, I.T.55.00.0$198,546$0$17,621Yes (X)
Linda Fisk
SVP, Marketing (BEG. 5/18)55.00.0$161,063$0$3,779Yes (X)
Sue Aldana
VP, Collaborative Revenue55.00.0$163,312$0$19,864Yes (X)
Carrie Hodges
Sr. Dir, ACC STR & Stewardship55.00.0$177,509$0$12,556Yes (X)
Subhendu Rath
Sr. Dir, IT Enterprise Systems55.00.0$169,182$0$29,510Yes (X)
Vanessa Hewitt
Sr. Dir., Internal Audit55.00.0$163,029$0$28,776Yes (X)
Kimberly Sabelko
Sr. Dir., Scientific Strategy55.00.0$159,567$0$27,873Yes (X)
Ellen Willmott
Former Officer0.00.0$225,255$0$15,697Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$3,679,441TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$328,376TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K51IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedYes (true)FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (true)TotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmtAddress Line1ContractorAddress/ForeignAddress/AddressLine1TxtCityContractorAddress/ForeignAddress/CityNmProvince Or StateContractorAddress/ForeignAddress/ProvinceOrStateNmCountryContractorAddress/ForeignAddress/CountryCdForeign PostalContractorAddress/ForeignAddress/ForeignPostalCd
Event 360
205 N MICHIGAN AVECHICAGOIL60601EVENT MANAGEMENT$5,238,270
STEPHEN THOMAS LTD
DIRECT MARKETING SVC$1,964,389184 FRONT STREET EAST SUITE 501TORONTOONTARIOCAM5A 4N3
THE ADVERTISING COUNCIL inc
815 SECOND AVENUE 9TH FLOORNEW YORKNY10017MARKETING$1,182,990
Wasserman Media Group LLC
10900 Wilshire Blvd Suite 1200LOS ANGELESCA90024CONSULTING$550,099
BLACKBAUD INC
6111 W PLANO PKWY STE 1000YCPLANOTX75093CONSULTING$540,303
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K18CntrctRcvdGreaterThan100KCnt
Federated Campaigns$224,516FederatedCampaignsAmt
Fundraising$15,125,344FundraisingAmt
All Other Contributions$47,942,127AllOtherContributionsAmt
Noncash Contributions$167,207NoncashContributionsAmt
Total Contributions$63,291,987TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp

FieldValueIRS element (for citing)
DescAffiliate Program FundingDesc
Business900099BusinessCd
Total Revenue Column$12,975,072TotalRevenueColumnAmt
Related Or Exempt Func Income$12,975,072RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$12,975,072TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$5,202,470TotalRevenueColumnAmt
Exclusion$5,202,470ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$19,231TotalRevenueColumnAmt
Exclusion$19,231ExclusionAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Exclusion$0ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$55,650,573SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$45,437,327SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$10,213,246SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$10,213,246TotalRevenueColumnAmt
Exclusion$10,213,246ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$549,746FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$15,125,344ContriRptFundraisingEventAmt
Fundraising Direct Expenses$3,024,262FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column-$2,474,516TotalRevenueColumnAmt
Exclusion-$2,474,516ExclusionAmt
FieldValueIRS element (for citing)
Gaming Gross Income$0GamingGrossIncomeAmt
Gaming Direct Expenses$0GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Exclusion$0ExclusionAmt
FieldValueIRS element (for citing)
Gross Sales Of Inventory$44,254GrossSalesOfInventoryAmt
Cost Of Goods Sold$56,749CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column-$12,495TotalRevenueColumnAmt
Related Or Exempt Func Income-$12,495RelatedOrExemptFuncIncomeAmt

Other Revenue Misc OtherRevenueMiscGrp (3 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmtUnrelated Business RevenueUnrelatedBusinessRevenueAmtExclusionExclusionAmt
Intercompany revenues900099$449,435$0$0$449,435
Shared services income900099$359,169$359,169$0$0
Other Income900099$34,200$0$60,395-$26,195
FieldValueIRS element (for citing)
Other Revenue Total$842,804OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$90,057,799TotalRevenueColumnAmt
Related Or Exempt Func Income$13,321,746RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$60,395UnrelatedBusinessRevenueAmt
Exclusion$13,383,671ExclusionAmt
FieldValueIRS element (for citing)
Info In Schedule O Part IXYes (X)InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$27,311,934TotalAmt
Program Services$27,311,934ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$2,169,651TotalAmt
Program Services$2,169,651ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$2,815,687TotalAmt
Program Services$1,005,240ProgramServicesAmt
Management And General$1,336,665ManagementAndGeneralAmt
Fundraising$473,782FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$16,452,459TotalAmt
Program Services$5,833,744ProgramServicesAmt
Management And General$7,828,105ManagementAndGeneralAmt
Fundraising$2,790,610FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$655,698TotalAmt
Program Services$236,521ProgramServicesAmt
Management And General$312,031ManagementAndGeneralAmt
Fundraising$107,146FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$1,814,136TotalAmt
Program Services$593,511ProgramServicesAmt
Management And General$920,148ManagementAndGeneralAmt
Fundraising$300,477FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$1,124,286TotalAmt
Program Services$416,047ProgramServicesAmt
Management And General$513,157ManagementAndGeneralAmt
Fundraising$195,082FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$168,066TotalAmt
Program Services$44,819ProgramServicesAmt
Management And General$54,031ManagementAndGeneralAmt
Fundraising$69,216FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$309,286TotalAmt
Program Services$0ProgramServicesAmt
Management And General$309,286ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$232,527TotalAmt
Program Services$232,527ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$2,527,973TotalAmt
Fundraising$2,527,973FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$193,238TotalAmt
Program Services$0ProgramServicesAmt
Management And General$193,238ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$3,865TotalAmt
Program Services$2,223ProgramServicesAmt
Management And General$966ManagementAndGeneralAmt
Fundraising$676FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$3,729,462TotalAmt
Program Services$1,792,238ProgramServicesAmt
Management And General$946,827ManagementAndGeneralAmt
Fundraising$990,397FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$9,609,107TotalAmt
Program Services$5,661,994ProgramServicesAmt
Management And General$200,577ManagementAndGeneralAmt
Fundraising$3,746,536FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$1,816,388TotalAmt
Program Services$1,180,652ProgramServicesAmt
Management And General$290,622ManagementAndGeneralAmt
Fundraising$345,114FundraisingAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$1,063,438TotalAmt
Program Services$414,106ProgramServicesAmt
Management And General$504,201ManagementAndGeneralAmt
Fundraising$145,131FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$1,613,882TotalAmt
Program Services$714,869ProgramServicesAmt
Management And General$732,185ManagementAndGeneralAmt
Fundraising$166,828FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$552,188TotalAmt
Program Services$391,509ProgramServicesAmt
Management And General$120,277ManagementAndGeneralAmt
Fundraising$40,402FundraisingAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$175TotalAmt
Program Services$35ProgramServicesAmt
Management And General$140ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$427,562TotalAmt
Program Services$79,217ProgramServicesAmt
Management And General$275,582ManagementAndGeneralAmt
Fundraising$72,763FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$333,755TotalAmt
Program Services$166,878ProgramServicesAmt
Management And General$83,439ManagementAndGeneralAmt
Fundraising$83,438FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
CONSULTING & PROF.SVCS.$10,851,269$9,309,593$1,032,401$509,275
EVENT PRODUCTION$2,920,637$1,987,977$277,112$655,548
EQUIP. RENTAL & MAINT.$1,406,703$423,225$848,163$135,315
Bank Fees$898,851$517,744$148,187$232,920

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$1,023,974TotalAmt
Program Services$607,482ProgramServicesAmt
Management And General$293,831ManagementAndGeneralAmt
Fundraising$122,661FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$92,026,197TotalAmt
Program Services$61,093,736ProgramServicesAmt
Management And General$17,221,171ManagementAndGeneralAmt
Fundraising$13,711,290FundraisingAmt
FieldValueIRS element (for citing)
Joint CostsYes (X)JointCostsInd

Total Joint Costs TotalJointCostsGrp

FieldValueIRS element (for citing)
Total$35,267,442TotalAmt
Program Services$20,475,918ProgramServicesAmt
Management And General$640,144ManagementAndGeneralAmt
Fundraising$14,151,380FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$31,040,869BOYAmt
EOY$17,950,693EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$18,645,179BOYAmt
EOY$26,578,028EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$209,655BOYAmt
EOY$217,555EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$1,215,980BOYAmt
EOY$1,410,475EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$9,431,581LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$8,498,691LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$1,168,202BOYAmt
EOY$932,890EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$101,757,276BOYAmt
EOY$77,611,324EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$47,753,580BOYAmt
EOY$67,428,258EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$20,773BOYAmt
EOY$20,773EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$201,811,514BOYAmt
EOY$192,149,996EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$6,873,683BOYAmt
EOY$8,480,242EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$70,283,876BOYAmt
EOY$66,857,399EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$247,500BOYAmt
EOY$191,470EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$77,405,059BOYAmt
EOY$75,529,111EOYAmt
FieldValueIRS element (for citing)
Organization Follows SFAS117Yes (X)OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

FieldValueIRS element (for citing)
BOY$86,358,517BOYAmt
EOY$67,602,118EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$37,722,938BOYAmt
EOY$48,693,767EOYAmt

Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$325,000BOYAmt
EOY$325,000EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$124,406,455BOYAmt
EOY$116,620,885EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$201,811,514BOYAmt
EOY$192,149,996EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss-$1,968,398ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst-$7,539,434NetUnrlzdGainsLossesInvstAmt
Donated Services And Use Fclts$39,999DonatedServicesAndUseFcltsAmt
Investment Expense$0InvestmentExpenseAmt
Prior Period Adjustments$0PriorPeriodAdjustmentsAmt
Other Changes In Net Assets$1,682,263OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredfalseFederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$77,337,857CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$105,234,559CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$55,634,984CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$51,441,732CurrentTaxYearMinus1YearAmt
Current Tax Year$63,291,987CurrentTaxYearAmt
Total$352,941,119TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$77,337,857CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$105,234,559CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$55,634,984CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$51,441,732CurrentTaxYearMinus1YearAmt
Current Tax Year$63,291,987CurrentTaxYearAmt
Total$352,941,119TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$42,585,598SubstantialContributorsTotAmt
Public Support Total170$310,355,521PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$3,542,123CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$2,523,145CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$2,265,964CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$5,667,273CurrentTaxYearMinus1YearAmt
Current Tax Year$5,221,701CurrentTaxYearAmt
Total$19,220,206TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$0CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$0CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$0CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$0CurrentTaxYearMinus1YearAmt
Current Tax Year$0CurrentTaxYearAmt
Total$0TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$153,632CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$336,857CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$51,821CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$124,523CurrentTaxYearMinus1YearAmt
Current Tax Year$34,200CurrentTaxYearAmt
Total$701,033TotalAmt
FieldValueIRS element (for citing)
Total Support$372,862,358TotalSupportAmt
Gross Receipts Rltd Activities$90,730,880GrossReceiptsRltdActivitiesAmt
Public Support CY1700.83236PublicSupportCY170Pct
Public Support PY1700.85794PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
Organization Belongs Afflt GrpYes (X)OrganizationBelongsAffltGrpInd

Total Grassroots Lobbying TotalGrassrootsLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$46,137FilingOrganizationsTotalAmt
Affiliated Group Total$64,115AffiliatedGroupTotalAmt

Total Direct Lobbying TotalDirectLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$186,390FilingOrganizationsTotalAmt
Affiliated Group Total$215,154AffiliatedGroupTotalAmt

Total Lobbying Expend TotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$232,527FilingOrganizationsTotalAmt
Affiliated Group Total$279,269AffiliatedGroupTotalAmt

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$74,572,499FilingOrganizationsTotalAmt
Affiliated Group Total$144,099,673AffiliatedGroupTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$74,805,026FilingOrganizationsTotalAmt
Affiliated Group Total$144,378,942AffiliatedGroupTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Filing Organizations Total$1,000,000FilingOrganizationsTotalAmt
Affiliated Group Total$1,000,000AffiliatedGroupTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Filing Organizations Total$250,000FilingOrganizationsTotalAmt
Affiliated Group Total$250,000AffiliatedGroupTotalAmt
FieldValueIRS element (for citing)
Tot Lbbyng Grassroot Mns Non TxTotLbbyngGrassrootMnsNonTxGrp
Tot Lbby Expend Mns Lbbyng Non TxTotLbbyExpendMnsLbbyngNonTxGrp

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Current Year Minus3$1,000,000CurrentYearMinus3Amt
Current Year Minus2$1,000,000CurrentYearMinus2Amt
Current Year Minus1$1,000,000CurrentYearMinus1Amt
Current Year$1,000,000CurrentYearAmt
Total$4,000,000TotalAmt
FieldValueIRS element (for citing)
Lobbying Ceiling$6,000,000LobbyingCeilingAmt

Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$218,796CurrentYearMinus3Amt
Current Year Minus2$274,215CurrentYearMinus2Amt
Current Year Minus1$253,525CurrentYearMinus1Amt
Current Year$279,269CurrentYearAmt
Total$1,025,805TotalAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Current Year Minus3$250,000CurrentYearMinus3Amt
Current Year Minus2$250,000CurrentYearMinus2Amt
Current Year Minus1$250,000CurrentYearMinus1Amt
Current Year$250,000CurrentYearAmt
Total$1,000,000TotalAmt
FieldValueIRS element (for citing)
Grassroots Ceiling$1,500,000GrassrootsCeilingAmt

Avg Grassroots Lobbying Expend AvgGrassrootsLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$66,033CurrentYearMinus3Amt
Current Year Minus2$19,341CurrentYearMinus2Amt
Current Year Minus1$19,478CurrentYearMinus1Amt
Current Year$64,115CurrentYearAmt
Total$168,967TotalAmt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceLOBBYING EXPENSESFormAndLineReferenceDesc
ExplanationSCHEDULE C, PART II-A PUBLIC POLICY INITIATIVES HAVE THE POTENTIAL TO IMPACT PEOPLE TOUCHED BY BREAST CANCER. RECOGNIZING THE POWER OF ADVOCACY TO ACCOMPLISH ITS MISSION, KOMEN SUPPORTS LIMITED LOBBYING ACTIVITIES TO ACHIEVE EVIDENCE BASED POLICY AND LEGISLATIVE SOLUTIONS DESIGNED TO END BREAST CANCER FOREVER.ExplanationTxt

Schedule D IRS990ScheduleD

FieldValueIRS element (for citing)
Art Public Exhibition AmountsArtPublicExhibitionAmountsGrp
Held Works ArtHeldWorksArtGrp

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$1,362,090BeginningYearBalanceAmt
Contributions$0ContributionsAmt
Investment Earnings Or Losses-$4,016InvestmentEarningsOrLossesAmt
Grants Or Scholarships$0GrantsOrScholarshipsAmt
Other Expenditures$24,267OtherExpendituresAmt
Administrative Expenses$204AdministrativeExpensesAmt
End Year Balance$1,333,603EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$1,377,855BeginningYearBalanceAmt
Contributions$0ContributionsAmt
Investment Earnings Or Losses$10,034InvestmentEarningsOrLossesAmt
Grants Or Scholarships$0GrantsOrScholarshipsAmt
Other Expenditures$25,799OtherExpendituresAmt
Administrative Expenses$0AdministrativeExpensesAmt
End Year Balance$1,362,090EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$1,376,069BeginningYearBalanceAmt
Investment Earnings Or Losses$1,786InvestmentEarningsOrLossesAmt
Other Expenditures$0OtherExpendituresAmt
End Year Balance$1,377,855EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$1,346,721BeginningYearBalanceAmt
Investment Earnings Or Losses$29,808InvestmentEarningsOrLossesAmt
Other Expenditures$460OtherExpendituresAmt
End Year Balance$1,376,069EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$1,346,267BeginningYearBalanceAmt
Investment Earnings Or Losses$4,717InvestmentEarningsOrLossesAmt
Other Expenditures$4,263OtherExpendituresAmt
End Year Balance$1,346,721EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY0.75000BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY0.24000PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY0.01000TermEndowmentBalanceEOYPct
Endowments Held Unrelated OrgfalseEndowmentsHeldUnrelatedOrgInd
Endowments Held Related OrgfalseEndowmentsHeldRelatedOrgInd

Land LandGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$0InvestmentCostOrOtherBasisAmt
Book Value$0BookValueAmt

Buildings BuildingsGrp

FieldValueIRS element (for citing)
Depreciation$0DepreciationAmt

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$610,067OtherCostOrOtherBasisAmt
Depreciation$293,736DepreciationAmt
Book Value$316,331BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$2,475,592OtherCostOrOtherBasisAmt
Depreciation$2,232,574DepreciationAmt
Book Value$243,018BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$6,345,922OtherCostOrOtherBasisAmt
Depreciation$5,972,381DepreciationAmt
Book Value$373,541BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$932,890TotalBookValueLandBuildingsAmt
Financial DerivativesFinancialDerivativesGrp
Closely Held Equity InterestsCloselyHeldEquityInterestsGrp

Other Securities OtherSecuritiesGrp (2 entries)

DescDescBook ValueBookValueAmtMethod ValuationMethodValuationCd
Defensive equity fund$19,773,258F
Private Equity fund$47,655,000F
FieldValueIRS element (for citing)
Total Book Value Securities$67,428,258TotalBookValueSecuritiesAmt
Federal Income Tax Liability$0FederalIncomeTaxLiabilityAmt
Total Liability$0TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Intended use of endowment fundsSCHEDULE D, PART V, LINE 4 KOMEN HAS THREE PERMANENT ENDOWMENTS: GOODMAN-BRINKER, FIRNBERG, AND A GENERAL ENDOWMENT. THE GOODMAN-BRINKER ENDOWMENT IS FOR BREAST CANCER RESEARCH FELLOWSHIPS, THE FIRNBERG ENDOWMENT IS FOR BREAST CANCER EDUCATIONAL PROGRAMS AND RESEARCH AWARDS, AND THE GENERAL ENDOWMENT'S EARNINGS ARE RESTRICTED FOR ORGANIZATIONAL MISSION ACTIVITIES.
FIN 48 (ASC 740) FINANCIAL STATEMENT DISCLOSURESCHEDULE D, PART X, LINE 2 THE ORGANIZATION IS SUBJECT TO A RECOGNITION THRESHOLD AND MEASUREMENT ATTRIBUTE FOR FINANCIAL STATEMENT RECOGNITION AND MEASUREMENT OF A TAX POSITION TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN. THERE WERE NO UNCERTAIN TAX POSITIONS RECORDED IN THE CONSOLIDATED FINANCIAL STATEMENTS AT MARCH 31, 2019 OR MARCH 31, 2018.

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (16 entries)

RegionRegionTxtEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
East Asia and the Pacific3GrantmakingResearch$339,873
Central America and the Caribbean2GrantmakingEducation$33,104
Central America and the Caribbean1GrantmakingScreening$5,000
Europe (Including Iceland and Greenland)1Program ServicesLegal Services$1,449
Europe (Including Iceland and Greenland)1GrantmakingEducation$75,000
Europe (Including Iceland and Greenland)10GrantmakingResearch$889,080
North America1GrantmakingEducation$120,000
North America2GrantmakingScreening & Treatment$135,756
North America4GrantmakingResearch$492,282
North America1FundraisingDirect Mail Processing$9,817,849
North America4Program ServicesMarketing Services$59,625
North America1Program ServicesSoftware Maintenance$5,242
South America1GrantmakingEducation$1,500
South America1Program ServicesConsulting$4,651
Sub-Saharan Africa1GrantmakingResearch$78,056
North America1Program ServicesConsulting$3,600
FieldValueIRS element (for citing)
Subtotal Employees35SubtotalEmployeesCnt
Total Employee35TotalEmployeeCnt
Subtotal Spent$12,062,067SubtotalSpentAmt
Total Spent$12,062,067TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (28 entries)

RegionRegionTxtPurpose Of GrantPurposeOfGrantTxtCash GrantCashGrantAmtManner Of Cash DisbursementMannerOfCashDisbursementTxt
Central America and the CaribbeanScreening Education Education Research Education Education Research Research Screening Research Research Screening Screening Research Research Research Treatment Research Education Research Research Education Research Education Research Research Research Research EDUCATION, TREATMENT RESEARCH RESEARCH, SCREENING, EDUCATION Treatment Research Research Education, Screening and Treatment Education Treatment Research Research Research Education Treatment Research Treatment Research Research Research Education and Treatment Treatment Research Research Research Research Research Research Treatment Research Education Research Treatment Education Research Research Education Research Research Research Research Research Research Education Treatment Research Research Treatment Screening and Treatment Research Education Education Treatment Education and Treatment Research Research Research Research Research Research Research Education Research Education, Screening, Treatment Research Education Edu$7,104WIRE TRANSFE
North AmericaResearch$135,756WIRE TRANSFE
Central America and the CaribbeanTreatment$16,000WIRE TRANSFE
Europe (Including Iceland and Greenland)RESEARCH$30,000WIRE TRANSFE
North AmericaResearch$138,750WIRE TRANSFE
North AmericaEducation$27,100WIRE TRANSFE
East Asia and the PacificResearch$53,781WIRE TRANSFE
North AmericaResearch$89,854WIRE TRANSFE
Europe (including Iceland and Greenland)Education$126,716WIRE TRANSFE
East Asia and the PacificResearch$149,790WIRE TRANSFE
Europe (including Iceland and Greenland)Screening$149,540WIRE TRANSFE
East Asia and the PacificResearch$75,000WIRE TRANSFE
Central America and the CaribbeanTreatment$10,000WIRE TRANSFE
Sub-Saharan AfricaEducation$78,056WIRE TRANSFE
Europe (including Iceland and Greenland)Education$36,000WIRE TRANSFE
Europe (including Iceland and Greenland)Research$75,000WIRE TRANSFE
Europe (including Iceland and Greenland)Research$81,000WIRE TRANSFE
Europe (including Iceland and Greenland)Research$23,760WIRE TRANSFE
Europe (including Iceland and Greenland)Research$158,085WIRE TRANSFE
North AmericaResearch$49,964WIRE TRANSFE
Europe (including Iceland and Greenland)Research$7,978WIRE TRANSFE
Europe (including Iceland and Greenland)Research$36,000WIRE TRANSFE
East Asia and the PacificResearch$61,301WIRE TRANSFE
North AmericaEducation, Screening Treatment$66,612WIRE TRANSFE
North AmericaRESEARCH$120,000WIRE TRANSFE
Europe (including Iceland and Greenland)Research$120,000WIRE TRANSFE
North AmericaEDUCATION$120,000WIRE TRANSFE
Europe (Including Iceland and Greenland)EDUCATION$120,000WIRE TRANSFE
FieldValueIRS element (for citing)
Total501c3 Org25Total501c3OrgCnt
Transfer To Foreign CorpfalseTransferToForeignCorpInd
Interest In Foreign TrustfalseInterestInForeignTrustInd
Foreign Corp OwnershipYes (true)ForeignCorpOwnershipInd
Passive Foreign Investmest CofalsePassiveForeignInvestmestCoInd
Foreign PartnershipfalseForeignPartnershipInd
Boycott CountriesfalseBoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePROCEDURES FOR MONITORING USE OF GRANT FUNDS OUTSIDE OF THE UNITED STATESFormAndLineReferenceDesc
ExplanationSCHEDULE F, PART I, LINE 2 AS OUTLINED IN EACH GRANT AGREEMENT, ALL GRANTEES ARE REQUIRED TO SUBMIT, AT A MINIMUM, ONE FINANCIAL AND PROGRESS REPORT WITHIN EACH YEAR OF THE GRANT TERM, AND ANY CHANGE REQUESTS THEY MAY HAVE FOR THEIR PROJECTS. ALL PROGRESS REPORTS AND REQUESTS ARE REVIEWED BY QUALIFIED STAFF. SEE SCHEDULE I, PART IV FOR MORE DETAILS.ExplanationTxt

Schedule G IRS990ScheduleG

FieldValueIRS element (for citing)
Mail SolicitationsYes (X)MailSolicitationsInd
Email SolicitationsYes (X)EmailSolicitationsInd
Phone SolicitationsYes (X)PhoneSolicitationsInd
In Person SolicitationsYes (X)InPersonSolicitationsInd
Solicitation Of Non Govt GrantsYes (X)SolicitationOfNonGovtGrantsInd
Special Fundraising EventsYes (X)SpecialFundraisingEventsInd
Agrmt Prof Fundraising ActyYes (true)AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp (10 entries)

ActivityActivityTxtFundraiser Control Of FundsFundraiserControlOfFundsIndGross ReceiptsGrossReceiptsAmtRetained By ContractorRetainedByContractorAmtNet To OrganizationNetToOrganizationAmtAddress Line1ForeignAddress/AddressLine1TxtCityForeignAddress/CityNmProvince Or StateForeignAddress/ProvinceOrStateNmCountryForeignAddress/CountryCdForeign PostalForeignAddress/ForeignPostalCd
EVENT 360
FUNDRAISING CONSULTINGfalse$16,586,106$1,309,568$15,276,538
STEPHEN THOMAS LTD
DIRECT MARKETINGfalse$12,858,860$785,756$12,073,104184 FRONT STREET EAST SUITE 501TORONTOONTARIOCAM5A 4N3
INFINITE AGENCY
MARKETING CONSULTINGfalse$2,050,109$164,632$1,885,477
BOB CARTER COMPANIES
FUNDRAISING CONSULTINGfalse$15,069
BLUE STATE DIGITAL INC
FUNDRAISING CONSULTINGfalse$70,000
TURNKEY PROMOTIONS INC
FUNDRAISING CONSULTINGfalse$66,377
RKD GROUP LLC
FUNDRAISING CONSULTINGfalse$40,800
REVUNAMI INC
FUNDRAISING CONSULTINGfalse$36,831
GROW FUNDRAISING CONSULTING INC
FUNDRAISING CONSULTINGfalse$3,361$25,190-$21,829
CAUSEFORCE LLC
FUNDRAISING CONSULTINGfalse$13,750
FieldValueIRS element (for citing)
Total Gross Receipts$31,498,436TotalGrossReceiptsAmt
Total Retained By Contractors$2,527,973TotalRetainedByContractorsAmt
Total Net To Organization$29,213,290TotalNetToOrganizationAmt
Licensed StatesALLicensedStatesCd
Licensed StatesAKLicensedStatesCd
Licensed StatesAZLicensedStatesCd
Licensed StatesARLicensedStatesCd
Licensed StatesCALicensedStatesCd
Licensed StatesCOLicensedStatesCd
Licensed StatesCTLicensedStatesCd
Licensed StatesDCLicensedStatesCd
Licensed StatesFLLicensedStatesCd
Licensed StatesGALicensedStatesCd
Licensed StatesHILicensedStatesCd
Licensed StatesIDLicensedStatesCd
Licensed StatesILLicensedStatesCd
Licensed StatesINLicensedStatesCd
Licensed StatesIALicensedStatesCd
Licensed StatesKSLicensedStatesCd
Licensed StatesKYLicensedStatesCd
Licensed StatesLALicensedStatesCd
Licensed StatesMELicensedStatesCd
Licensed StatesMDLicensedStatesCd
Licensed StatesMALicensedStatesCd
Licensed StatesMILicensedStatesCd
Licensed StatesMNLicensedStatesCd
Licensed StatesMSLicensedStatesCd
Licensed StatesMOLicensedStatesCd
Licensed StatesMTLicensedStatesCd
Licensed StatesNELicensedStatesCd
Licensed StatesNVLicensedStatesCd
Licensed StatesNHLicensedStatesCd
Licensed StatesNJLicensedStatesCd
Licensed StatesNMLicensedStatesCd
Licensed StatesNYLicensedStatesCd
Licensed StatesNCLicensedStatesCd
Licensed StatesNDLicensedStatesCd
Licensed StatesOHLicensedStatesCd
Licensed StatesOKLicensedStatesCd
Licensed StatesORLicensedStatesCd
Licensed StatesPALicensedStatesCd
Licensed StatesRILicensedStatesCd
Licensed StatesSCLicensedStatesCd
Licensed StatesSDLicensedStatesCd
Licensed StatesTNLicensedStatesCd
Licensed StatesTXLicensedStatesCd
Licensed StatesUTLicensedStatesCd
Licensed StatesVTLicensedStatesCd
Licensed StatesVALicensedStatesCd
Licensed StatesWALicensedStatesCd
Licensed StatesWVLicensedStatesCd
Licensed StatesWILicensedStatesCd
Licensed StatesWYLicensedStatesCd

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event13 Day 7Event1Nm
Gross Receipts Event1$14,353,334GrossReceiptsEvent1Amt
Charitable Contri Event1$13,980,368CharitableContriEvent1Amt
Gross Revenue Event1$372,966GrossRevenueEvent1Amt
Non Cash Prizes Event1$11,524NonCashPrizesEvent1Amt
Rent Facility Costs Event1$902,892RentFacilityCostsEvent1Amt
Food And Beverage Event1$907,907FoodAndBeverageEvent1Amt
Other Direct Expenses Event1$964,519OtherDirectExpensesEvent1Amt
Event2DC Walk 1Event2Nm
Gross Receipts Event2$839,530GrossReceiptsEvent2Amt
Charitable Contri Event2$672,945CharitableContriEvent2Amt
Gross Revenue Event2$166,585GrossRevenueEvent2Amt
Non Cash Prizes Event2$8,204NonCashPrizesEvent2Amt
Rent Facility Costs Event2$51,371RentFacilityCostsEvent2Amt
Food And Beverage Event2$29,701FoodAndBeverageEvent2Amt
Other Direct Expenses Event2$3,844OtherDirectExpensesEvent2Amt
Other Events Total2OtherEventsTotalCnt
Gross Receipts Other Events$482,226GrossReceiptsOtherEventsAmt
Charitable Contri Other Events$472,031CharitableContriOtherEventsAmt
Gross Revenue Other Events$10,195GrossRevenueOtherEventsAmt
Non Cash Prizes Other Events$54,668NonCashPrizesOtherEventsAmt
Rent Fclty Costs Other Events$10,201RentFcltyCostsOtherEventsAmt
Food And Beverage Other Events$26,748FoodAndBeverageOtherEventsAmt
Entertainment Other Events$35,000EntertainmentOtherEventsAmt
Oth Direct Expnss Other Events$17,683OthDirectExpnssOtherEventsAmt
Gross Receipts Total$15,675,090GrossReceiptsTotalAmt
Charitable Contributions Tot$15,125,344CharitableContributionsTotAmt
Gross Revenue Total Events$549,746GrossRevenueTotalEventsAmt
Non Cash Prizes Total Events$74,396NonCashPrizesTotalEventsAmt
Rent Fclty Costs Total Events$964,464RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events$964,356FoodAndBeverageTotalEventsAmt
Entertainment Total Events$35,000EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events$986,046OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$3,024,262DirectExpenseSummaryEventsAmt
Net Income Summary-$2,474,516NetIncomeSummaryAmt

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
SCHEDULE G PART ITHE MAJORITY OF FUNDRAISING CONSULTING COSTS WITHOUT CORRESPONDING GROSS RECEIPTS ARE ASSOCIATED WITH KOMEN'S AFFILIATE NETWORK FUNDRAISING EFFORTS. THE GROSS RECEIPTS ARE RETAINED BY THE AFFILIATES.
NET INCOME SUMMARYSCHEDULE G PART II Gross receipts are reduced by the amount of contributions, per IRS instructions. The contributions for fiscal year 2019 were $15,125,344.

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Recipient Table RecipientTable (136 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxt
African Women's Cancer Awareness Assoc
333 Cottman AvenuePhiladelphiaPA19111731704355501c3$28,321Education
Albany Medical College
ATTN FRANCES ALBERTALBANYNY12208141338310501c3$150,000Research
American Association for Cancer Research
615 CHESTNUT 17TH FLPHILADELPHIAPA19106236251649501c3$90,000Research
American Association on Health & Disabil
110 N WASHINGTON ST STE 328JROCKVILLEMD20850521884887501c3$84,907Research
American Jewish Joint
ATTN ITAI SHAMIRNEW YORKNY100174014131656634501c3$83,460Education
Arlington Free Clinic
2921 11TH STREETSOUTH ARLINGTONVA22204541671883501c3$29,999Research
Baylor College Medicine
GRANTS ACCOUNTS RECEIVABLEHOUSTONTX770303411741613878501c3$803,148RESEARCH
Baylor University
ONE BEAR PLACE 97043WACOTX767987043741159753501c3$150,000Research
Beth Israel Deaconess Medical Center
RESEARCH FINANCE OFFICE BR109BOSTONMA02215042103831501c3$149,510Research
Black Nurses Rock
2519 W CHESTNUTE AVEENIDOK73703710609582501c3$10,000EDUCATION
Boat People SOS
60066 LEESBURG PIKE 100FALLS CHURCHVA02220541563619501c3$21,027TREATMENT
Boston University
EVENTS CONFERENCESBOSTONMA02215042103547501c3$100,000RESEARCH
Breast Care for Washington
4 ATLANTIC ST SWWASHINGTONDC20032455574713501c3$30,000TREATMENT
Brigham & Women's Hospital
PO BOX 3149BOSTONMA022413149042312909501c3$255,982Research
Broad Institute Inc
415 MAIN STREETCAMBRIDGEMA02142263428781501c3$12,000Research
Burnham Institute for Medical Research
CANCER CTRLA JOLLACA92037510197108501c3$123,111RESEARCH
Cancer Care
275 SEVENTH AVENUENEW YORKNY10001131825919501c3$2,389,297EDUCATION AND TREATMENT
CASA of Maryland Inc
ATTN JENNIFER FREEDMANHYATTSVILLEMD20783521372972501c3$15,000TREATMENT
Case Western Reserve University
CONTROLLERS OFFICECLEVELANDOH441067006341018992501c3$177,643RESEARCH
Children's Hospital Boston
RESEARCH FINANCEBOSTONMA022414413042774441501c3$48,000RESEARCH
Cold Spring Harbor Laboratory
ATTN WALTER GOLDSCHMIDTSCOLD SPRING HARBORNY11724112013303501c3$48,000Education, Screening, Treatment
Columbia University Medical Center
722 WEST 168TH STREET 4TH FLNEW YORKNY10032135598093501c3$340,000Research
Cornell University
ATTN ILENE LAMBIASEITHACANY14850150532082501c3$12,000Research
Dana Farber Cancer Institute
450I BROOKLINE AVENUE BP 412BOSTONMA022155450042263040501c3$1,412,417Research
Doctors Community Hospital
8118 GOOD LUCK ROADLANHAMMD20706521638026501c3$40,000TREATMENT
Duke University Medical Center
ATTN MARY JOHNSONDURHAMNC27701560532129501c3$378,014Research
Eastern Michigan University
ATTN SUSAN SHIPLEYYPSILANTIMI48197382953297501c3$87,500EDUCATION
Emory University Winship Cancer Inst
PO BOX 935084ATLANTAGA311935084580566256501c3$150,000Research
Ethiopian Community Development Council
ATTN AZEB TADESSEARLINGTONVA22204521308986501c3$30,000TREATMENT
Facing Our Risk of Cancer Empowered
16057 TAMPA PALMS BLVD W 373TAMPAFL33647650927702501c3$10,000EDUCATION
Fox Chase Cancer Center'
333 COTTMAN AVENUEPHILADELPHIAPA19111232003072501c3$90,000Research
Fred Hutchinson Cancer Research Center
PO BOX 19024 MS J6-330SEATTLEWA981091024563744111501c3$323,500Research
Georgia Tech Research Corporation
505 TENTH STREET NWATLANTAGA30318580603146501c3$150,000Research
H Lee Moffitt Cancer Center
12902 MAGNOLIA DRIVETAMPAFL33612593238636501c3$240,000Research
Harvard Medical School
HOLYOKE CENTER ROOM 600CAMBRIDGEMA02138042103580501c3$160,000RESEARCH
Harvard University
25 SHATTUCK STREETBOSTONMA02115042103580501c3$80,000Research
Henry Ford Health System
ONE FORD PLACE 5EDETROITMI48202381357020501c3$41,092Research
Holy Cross Health
ATTN ANNE GILLISSILVER SPRINGMD20910520738041501c3$6,380EDUCATION
Howard University
2041 GEORGIA AVENUE NWWASHINGTONDC20060530204707501c3$29,996TREATMENT
Indiana U (Indianapolis)
FINANCIAL MGMT SERVICESINDIANAPOLISIN462666057356001673501c3$1,230,000RESEARCH
Johns Hopkins University
1650 ORLEANS STREETBALTIMOREMD21231520595110501c3$2,117,480RESEARCH
Kingman Regional Medical Center
3269 STOCKTON HILL RDKINGMANAZ86409742388735501c3$7,473TREATMENT
Korean Community Svc Ctr of Greater WA
CTR OF GREATER WAANNANDALEVA22003386005984501c3$75,231SCREENING AND TREATMENT
Leland Stanford Jr University
PO BOX 44253SAN FRANCISCOCA941444253941156365501c3$120,000RESEARCH
Living Beyond Breast Cancer
ATTN JEAN SACHS CEOHAVERFORDPA19041530196932501c3$24,000Education
Maasai Wildernes Conservation Fund
PO BOX 1413SANTA BARBARACA93102541943145501c3$15,000EDUCATION
Maricopa Health Foundation
2910 E CAMELBACK ROAD SUITE 180PHOENIXAZ85016860777567501c3$7,500TREATMENT
Mary's Ctr for Maternal&Child Care Inc
2333 ONTARIO ROAD NWWASHINGTONDC20009521594116501c3$88,949Education AND TREATMENT
Massachusetts General Hospital
PO BOX 414876BOSTONMA022414876041564655501c3$137,681Research
Massachusetts Institute of Technology
160 MEMORIAL DRIVECAMBRIDGEMA02139042103594501c3$169,077RESEARCH
Mayo Clinic Jacksonville
GRIFFIN BUILDING ROOM 170JACKSONVILLEFL32224593337028501c3$200,000Research
Mayo Clinic Rochester
DBA MAYO CLINIC COLLEGE OF MEDICINEROCHESTERMN559034008416011702501c3$224,000Research
Medical College of Wisconsin
1234 ANY STREETANYWHERETX75244390806261501c3$150,000Research
Memorial Sloan-Kettering Cancer Ctr
633 3RD AVENUE 28TH FLNEW YORKNY10017131924236501c3$400,000RESEARCH
Metastasis Research Society
METASTASIS RESEARCH SOCIETYVESTAVIA HILLSAL35242251824374501c3$33,000Research
METAvivor Research and Support
312 SEVERN AVE W302ANNAPOLISMD21403371578088501c3$20,000EDUCATION
Mount Sinai School of Medicine
SPONSORED PROJ ACTGNEW YORKNY100296574136171197501c3$418,779RESEARCH
Mountain Park Health Cntr
ATTN KYLE MUNSONPHOENIXAZ85012860498020501c3$22,500EDUCATION, SCREENING, TREATMENT
National Black Nurses Association
8630 FENTON STREET SUITE 910SILVER SPRINGMD20910237194995501c3$7,000Education
National Minority Quality Forum Inc
1201 15TH ST NW SUITE 340WASHINGTONDC20005311750942501c3$50,000EDUCATION
New York University School of Med
ACCOUNTING/ACCOUNTS RECEIVABLENEW YORKNY10016135562308501c3$30,000RESEARCH
North Carolina Central University
1801 FAYETTEVILLE STREETDURHAMNC27707566000730501c3$81,000Research
North Country Community Health Center
2920 N 4TH STREETFLAGSTAFFAZ860041816860663432501c3$7,500TREATMENT
Northwestern University - Chicago
633 CLARKEVANSTONIL60208362167817501c3$389,366Research
Nueva Vida Inc
2000 P STREET NW SUITE 300WASHINGTONDC20036541943145501c3$28,634TREATMENT
Obesity Society
8757 GEORGIA AVENUESILVER SPRINGMD20910541438429501c3$11,000Research
Oregon Health & Science University
SPONSORED PROGRAM ADMINPORTLANDOR97239752668014501c3$2,183,734Research
Partners for Cancer Care and Prevention
10 EAST LEE STREET UNIT 1901BALTIMOREMD21202451605551501c3$67,500SCREENING
Princeton University
701 CARNEGIE CENTERPRINCETONNJ08540210634501501c3$320,000Research
Program for Appropriate
PO BOX 900922SEATTLEWV98109911157127501c3$14,246EDUCATION
Providence Health Foundation
1150 VARNUM ST NEWASHINGTOMDC20017521275583501c3$14,285EDUCATION
Providence Portland Medical Center
4805 NE GLISAN ST 5F40PORTLANDOR97213930386906501c3$30,000Research
Purdue University
SPONSORED PROGRAM SERVICESCHICAGOIL606731235356002041501c3$150,000Research
Regents of University of Michigan
ROOM 7110 CCGC INTERNAL MEDICINEANN ARBORMI481091274386006309501c3$12,000Research
Research Advocacy Network
6505 WEST PARK BLVDPLANOTX75093566001393501c3$47,539Research
Rockefeller University
ATTN SHAWN DAVISNEW YORKNY10065131624158501c3$90,000Research
Roswell Park Alliance Foundation
DEPARTMENT OF IMMUNOLOGYBUFFALONY14263161391608501c3$215,794Research
Stanford University
PO BOX 44253SAN FRANCISCOCA941444253941156365501c3$335,840Research
Stevens Institute of Technology
1 CASTLE POINT TERRACEHOBOKENNJ07030221487354501c3$36,000Research
SUNY at Stony Brook
ATTN JOANN DELUCIA-CONLONSTONY BROOKNY11794146013200501c3$299,872Research
Temple University
ATTN JEANNETTE WEST PASTELAKPHILADELPHIAPA19122231365971501c3$36,000Research
The Ohio State University College
ATTN KATHY MILEMCOLUMBUSOH43205316025986501c3$75,000Research
The Salk Institute
ATTN CHRISTINE MARCKESELA JOLLACA92037376000511501c3$100,000Research
The University of Chicago
RESEARCH ADMINISTRATIONCHICAGOIL60637362177139501c3$181,000Research
The University of Toledo
ATTN DR AMY THOMPSONTOLEDOOH436063390346401483501c3$149,958Research
The Vanderbilt University
PMB 406310NASHVILLETN372406310620476822501c3$112,049Research
The Wistar Institute
3601 SPRUCE STREETPHILADELPHIAPA04265236434390501c3$150,000Research
Trustees of Columbia Univ
SPONSORED PROJECTS FINANCENEW YORKNY10027135598093501c3$120,000Research
Trustees of Dartmouth College
OFFICE OF SPONSORED PROJECTSHANOVERNH037551404020222111501c3$29,999Research
Tulane University Health Sciences Center
800 E COMMERCEHARAHANLA70023720423889501c3$72,000Research
Univ of Colorado Health Sciences Cent
ATTN GEORGE JOHNSTONDENVERCO802910238846002597501c3$150,000Research
Univ of North Carolina at Chapel Hill
104 AIRORT DRIVE SUITE 2200 CB 1CHAPEL HILLNC275991350566001393501c3$1,647,977EDUCATION, SCREENING, TREATMENT
Univ of Texas MD Anderson Cancer Center
GRANTS CONTRACTSHOUSTONTX772104390746001118501c3$833,173Research
University Miami School of Medicine
ATTN MARIA A GARCIACORAL GABLESFL33146590624458501c3$30,000Research
University of Alabama at Birmingham
1530 3RD AVENUE SOUTHBIRMINGHAMAL352940111636005396501c3$27,000Research
University of California at San Francis
ANDREW BOULTERSAN FRANCISCOCA94118946036493501c3$200,000Research
University of California-Davis
CASHIERS OFFICEWEST SACRAMENTOCA957989062956006143501c3$35,992Research
University of California-Los Angeles
ADMINISTRATIVE MAIN CASHIER OFFICELOS ANGELESCA900959000956006143501c3$90,000Research
University of California-San Diego
USCD CASHIERS OFFICELA JOLLACA92093956006143501c3$41,999Research
University of California-San Francisco
1600 DIVISADERO ST BOX 1710SAN FRANCISCOCA94115956006143501c3$59,999Research
University of Delaware
30 LOVETT AVENUENEWARDDE19716516000279501c3$90,000Research
University of Illinois at Chicago
PO BOX 20787SPRINGFIELDIL627080787376000511501c3$66,938RESEARCH
University of Illinois--Urbana-Champaign
GRANTS CONTRACTS POST AWARDSPRINGFIELDIL10061376000511501c3$36,000Research
University of Kansas Center for Research
2385 IRVING HILL ROADLAWRENCEKS66045480680117501c3$150,000Research
University of Kansas Medical Center
ATTN TIM SISKEYKANSAS CITYKS66140481108830501c3$446,888Research
University of Kentucky Research Fndn
MARKEY CANCER CENTERLEXINGTONKY405260001616033693501c3$90,000Research
University of Massachusetts Amherst
Goodell Bldg Room 405AmherstMA010033210043167352501c3$89,549Education, Treatment
University of Miami School of Medicine
Center for Cancer Prevention and GeMiamiFL33136590624458501c3$36,000RESEARCH
University of Michigan
Alexandra ThebaudAnn ArborMI481091274386006309501c3$425,969Research
University of Michigan Health Systems
3003 S State St Rm 1054Ann ArborMI481091274386006309501c3$171,067RESEARCH
University of Minnesota
McNamara Alumni CenterMinneapolisMN554552070416007513501c3$80,000EDUCATION
University of Notre Dame du Lac
731 Grace HallNotre DameIL46556350868188501c3$179,990RESEARCH
University of Pennsylvania
Office of Research ServicesPhiladelphiaPA191046205231352685501c3$779,085EDUCATION
University of Pittsburgh
Office of ResearchPittsburghPA152132303250966691501c3$725,296RESEARCH
University of South CarolinaThe
1600 Hampton Street Suite 404HColumbiaSC29208576001153501c3$135,000RESEARCH
University of Southern California
Attn Robert OsunaLos AngelesCA900898001951642394501c3$234,778RESEARCH
University of Texas at Health Science Center
Elizabeth FrantzHoustonTX77030741587488501c3$135,000RESEARCH
University of Utah
201 South Presidents Circle RoomSalt Lake CityUT841129020876000525501c3$280,000RESEARCH
University of Virginia at School of Medi
PO Box 400195CharlottesvilleVA229044195876000525501c3$150,000RESEARCH
University of Washington
Attn Tami SaduskySeattleWA98105916001537501c3$260,000RESEARCH
University of Wisconsin - Madison
Research Sponsored ProgramsMadisonWI537151218396006492501c3$60,000RESEARCH
UT HSC - San Antonio
Office of Sponsored ProgramsSan AntonioTX772293900741586031501c3$475,634RESEARCH
UT Southwestern Medical Center
UT Southwestern Grants MgmtDallasTX752841753746000203501c3$190,000RESEARCH
Utah Cancer Control Program
Attn Shari WatkinsSalt Lake CityUT841144620876000545501c3$49,962SCREENING
UTMD Anderson Cancer Ctr
1515 Holcombe Boulevard Unit 1644HoustonTX770304009746001118501c3$174,103RESEARCH
Vanderbilt University Medical Center
Dept AT 40303AtlantaGA311920303620476822501c3$853,242RESEARCH
Vermont Cancer Ctr UVM College of Med
Attn Jennifer GagnonBurlingtonVT05405030219309501c3$104,719RESEARCH
Vietnamese Resettlement Association Inc
Attn Kim O CookFalls ChurchVA22044541512549501c3$19,942EDUCATION AND TREATMENT
Virginia Commonwealth University
Attn Presepine FlemingRichmondVA23284546001758501c3$150,000RESEARCH
Wake Forest University Health Sciences
Grants ManagementWinstonSalemNC27157223849199501c3$150,000RESEARCH
Washington University at St Louis Scho
700 Rosedale Avenue Campus Box 103Saint LouisMO63112430653611501c3$104,755EDUCATION, RESEARCH
Wayne State University
Attn Julie BoernerDetroitMI48201366028429501c3$60,000RESEARCH
Weill Medical College of Cornell Univ
1300 York AvenueNew YorkNY10061131623978501c3$60,000RESEARCH
Wesley Community Center
1300 S 10th StreetPhoenixAZ85034860133770501c3$7,500TREATMENT
Whitehead Inst for Biomedical Research
9 Cambridge CenterCambridgeMA021421479061043412501c3$12,000RESEARCH
Yale University
2 Whitney AvenueNew HavenCT06521060646973501c3$200,000RESEARCH
FieldValueIRS element (for citing)
Total501c3 Org136Total501c3OrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePROCEDURES FOR MONITORING THE USE OF GRANTSFormAndLineReferenceDesc
ExplanationSchedule I, PART I, LINE 2 SUSAN G. KOMEN'S (KOMEN) POLICIES FOR MANAGING GRANTS FROM THE TIME OF PRE-AWARD THROUGH CLOSEOUT ARE DESIGNED TO MAXIMIZE FLEXIBILITY WHILE MAINTAINING A HIGH STANDARD OF ACCOUNTABILITY AND PRESERVING THE INTEGRITY OF THE REVIEW AND AWARD PROCESS. KOMEN REQUIRES ALL GRANTEES TO SIGN A GRANT AGREEMENT SETTING FORTH THE TERMS OF THE GRANT, INCLUDING: PURPOSE, AMOUNT, BUDGETARY RESTRICTIONS, DURATION, PAYMENT SCHEDULE, REPORTING REQUIREMENTS, AUDIT, AND EARLY TERMINATION RIGHTS. FOR RESEARCH GRANTS, SCIENTIFIC PROGRESS AND FINANCIAL OVERSIGHT IS MONITORED THROUGHOUT THE GRANT TERM BY A PH.D. OR MASTERS-LEVEL RESEARCH GRANT MANAGER. FOR EDUCATION, SCREENING, AND TREATMENT GRANTS, PROGRESS AND FINANCIAL OVERSIGHT IS MONITORED OR SUPERVISED THROUGHOUT THE GRANT TERM BY QUALIFIED PROFESSIONALS SERVING AS GRANTS MANAGERS. EACH YEAR OF THE GRANT TERM, GRANTEES ARE REQUIRED TO SUBMIT PROGRESS AND FINANCIAL REPORTS DETAILING PROGRESS TOWARD AIMS AND OBJECTIVES, MAJOR ACCOMPLISHMENTS, KEY DELIVERABLES AND CHALLENGES ENCOUNTERED, WITH A FULL ACCOUNTING OF GRANT FUNDS EXPENDED (ACTUAL VERSUS BUDGETED EXPENSES) AND WRITTEN JUSTIFICATION OF EXPENSES. AS APPROPRIATE, THE GRANTS MANAGER MAY CONDUCT SITE VISITS WITH GRANTEES TO GAIN A BETTER UNDERSTANDING OF THEIR WORK AND ADDRESS ANY CHALLENGES IMPACTING THE FUNDED PROGRAM. ALL GRANT FUNDS MUST BE EXPENDED IN ACCORDANCE WITH THE PROJECT'S APPROVED BUDGET AND ARE DISBURSED IN ACCORDANCE WITH THE SCHEDULE DOCUMENTED WITHIN THE GRANT AGREEMENT. REQUESTS FOR CHANGES TO THE DESIGN OF THE FUNDED PROJECT OR BUDGET ARE SUBJECT TO PRIOR APPROVAL BY KOMEN IN ACCORDANCE WITH THE TERMS OF THE GRANT AGREEMENT. AS PART OF ITS OVERSIGHT PRACTICES, THE TERMS OF THE GRANT AGREEMENT MAY PROVIDE KOMEN WITH, AMONG OTHER THINGS, THE RIGHT TO REQUEST WITH REASONABLE PRIOR NOTICE TO THE GRANTEE: (1) ADDITIONAL PROGRESS AND/OR FINANCIAL REPORTING FROM THE GRANTEE, (2) GRANTEE PARTICIPATION IN SITE VISITS, TELEPHONE CONFERENCES, PRESENTATIONS, OR OTHER SPEAKING ENGAGEMENTS, AND (3) WITH PRIOR WRITTEN NOTICE, ADJUSTMENT TO THE PROJECT REPORTING PERIOD AND ASSOCIATED DISBURSEMENT OF GRANT FUNDS AT ANY TIME DURING THE GRANT TERM.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
First Class Or Charter TravelYes (X)FirstClassOrCharterTravelInd
Written Policy Ref T And E ExpnssYes (true)WrittenPolicyRefTAndEExpnssInd
Substantiation RequiredYes (true)SubstantiationRequiredInd
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Written Employment ContractYes (X)WrittenEmploymentContractInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentYes (true)SeverancePaymentInd
Supplemental Nonqual Rtr PlanfalseSupplementalNonqualRtrPlanInd
Equity Based Comp ArrngmfalseEquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgfalseCompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related OrgsfalseCompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgfalseCompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsfalseCompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsfalseAnyNonFixedPaymentsInd
Initial Contract ExceptionfalseInitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (16 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
Paula Schneider
President and CEO$546,901$0$0$0$5,124$0$0$0$7,081$0$559,106$0$0$0
Catherine Olivieri Beg 319
VP, HR and Corporate Secretary$221,648$0$0$0$3,758$0$14,137$0$31,431$0$270,974$0$0$0
Ria Williams Beg 1018
Chief Financial Officer$179,382$0$0$0$2,064$0$8,586$0$7,838$0$197,870$0$0$0
Robert Green End 1018
Chief Financial Officer$271,798$0$22,121$0$15,396$0$9,040$0$3,987$0$322,342$0$0$0
Adam Vanek END 219
GEN. COUNSEL & CORPORATE SECY$243,233$0$0$0$2,370$0$0$0$25,485$0$271,088$0$0$0
Christina Alford
SVP, Development$284,993$0$0$0$2,100$0$16,414$0$7,221$0$310,728$0$0$0
Victoria Wolodzko
VP RESEARCH AND COM. HEALTH PR$226,401$0$0$0$2,302$0$11,131$0$12,109$0$251,943$0$0$0
Lori Maris
SVP, Affiliate Network$185,646$0$0$0$2,623$0$7,616$0$10,484$0$206,369$0$0$0
Eric Montgomery
VP, I.T.$196,541$0$0$0$2,005$0$7,792$0$9,829$0$216,167$0$0$0
Linda Fisk
SVP, Marketing (BEG. 5/18)$130,039$0$25,000$0$6,024$0$0$0$3,779$0$164,842$0$0$0
Sue Aldana
VP, Collaborative Revenue$159,647$0$0$0$3,665$0$4,592$0$15,272$0$183,176$0$0$0
Carrie Hodges
Sr. Dir, ACC STR & Stewardship$175,738$0$0$0$1,771$0$10,638$0$1,918$0$190,065$0$0$0
Subhendu Rath
Sr. Dir, IT Enterprise Systems$167,313$0$0$0$1,869$0$10,195$0$19,315$0$198,692$0$0$0
Vanessa Hewitt
Sr. Dir., Internal Audit$161,167$0$0$0$1,862$0$10,151$0$18,625$0$191,805$0$0$0
Kimberly Sabelko
Sr. Dir., Scientific Strategy$157,063$0$0$0$2,504$0$9,401$0$18,472$0$187,440$0$0$0
Ellen Willmott
Former Officer$90,322$0$133,754$0$1,179$0$5,484$0$10,213$0$240,952$0$0$0

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceFORM 990, SCHEDULE J, PART I, LINE 1AFormAndLineReferenceDesc
ExplanationSUPPLEMENTAL COMPENSATION INFORMATION ONE TRIP DURING FY19 INCLUDED FIRST CLASS AIR FARE. ALL OTHER REIMBURSED TRAVEL EXPENSES DO NOT INCLUDE FIRST CLASS AIR FARE EXCEPT AS MAY BE APPROVED IN ADVANCE FOR MEDICAL ACCOMMODATION. HOWEVER, PERSONAL FREQUENT FLIER MILEAGE AND COUPONS MAY BE USED FOR NO COST UPGRADES. IN THE EVENT OF INTERNATIONAL TRAVEL WITH FLIGHT TIMES OF SIX HOURS OR MORE, AND PRE-APPROVAL, BUSINESS OR FIRST CLASS TRAVEL MAY BE PERMITTED IF THERE IS A MEDICAL ACCOMMODATION OR BUSINESS PURPOSE. WHENEVER POSSIBLE, DISCOUNTED FIRST CLASS AND UPGRADES ARE USED TO MINIMIZE COSTS. SEVERANCE PAYMENT FORM 990, SCHEDULE J, PART I, LINE 4A ROBERT GREEN RECEIVED A SEVERANCE PAYMENT OF $22,121. ELLEN WILLMOTT RECEIVED A SEVERANCE PAYMENT OF $133,754.ExplanationTxt

Schedule M IRS990ScheduleM

FieldValueIRS element (for citing)
Works Of ArtWorksOfArtGrp
Art Historical TreasuresArtHistoricalTreasuresGrp
Art Fractional InterestArtFractionalInterestGrp
Books And PublicationsBooksAndPublicationsGrp

Clothing And Household Goods ClothingAndHouseholdGoodsGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Noncash Contributions Rpt F990$73,616NoncashContributionsRptF990Amt
Method Of Determining RevenuesFMVMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Cars And Other VehiclesCarsAndOtherVehiclesGrp
Boats And PlanesBoatsAndPlanesGrp
Intellectual PropertyIntellectualPropertyGrp
Securities Publicly TradedSecuritiesPubliclyTradedGrp
Securities Closely Held StockSecuritiesCloselyHeldStockGrp
Secur Prtnrshp Trust IntrstsSecurPrtnrshpTrustIntrstsGrp

Securities Miscellaneous SecuritiesMiscellaneousGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution1ContributionCnt
Noncash Contributions Rpt F990$841NoncashContributionsRptF990Amt
Method Of Determining RevenuesFMVMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Qualified Contrib Hist StructQualifiedContribHistStructGrp
Qualified Contrib OtherQualifiedContribOtherGrp
Real Estate ResidentialRealEstateResidentialGrp
Real Estate CommercialRealEstateCommercialGrp
Real Estate OtherRealEstateOtherGrp

Collectibles CollectiblesGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution3ContributionCnt
Noncash Contributions Rpt F990$22,375NoncashContributionsRptF990Amt
Method Of Determining RevenuesFMVMethodOfDeterminingRevenuesTxt

Food Inventory FoodInventoryGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution3ContributionCnt
Noncash Contributions Rpt F990$20,875NoncashContributionsRptF990Amt
Method Of Determining RevenuesFMVMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Drugs And Medical SuppliesDrugsAndMedicalSuppliesGrp
TaxidermyTaxidermyGrp
Historical ArtifactsHistoricalArtifactsGrp
Scientific SpecimensScientificSpecimensGrp
Archaeological ArtifactsArchaeologicalArtifactsGrp

Other Non Cash Contri Table OtherNonCashContriTableGrp (2 entries)

Non Cash CheckboxNonCashCheckboxIndDescDescContributionContributionCntNoncash Contributions Rpt F990NoncashContributionsRptF990AmtMethod Of Determining RevenuesMethodOfDeterminingRevenuesTxt
Yes (X)Gift cards5$23,550fmv
Yes (X)Event venue1$25,950fmv
FieldValueIRS element (for citing)
Any Property That Must Be HeldfalseAnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (true)ReviewProcessUnusualNCGiftsInd
Third Parties UsedfalseThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE M, PART I, COLUMN (B)FormAndLineReferenceDesc
ExplanationTHE AMOUNTS IN THIS COLUMN REPRESENTS THE NUMBER OF ITEMS CONTRIBUTED OTHER THAN FOOD, WHICH IS NUMBER OF CONTRIBUTIONS.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (11 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART I, QUESTION 6 - VOLUNTEERSVOLUNTEERS SERVE IN A VARIETY OF WAYS, BUT THE GREATEST NUMBERS OF VOLUNTEERS ASSIST WITH THE SUSAN G. KOMEN 3 DAY SERIES.
FORM 990, PART III - PROGRAM SERVICE ACCOMPLISHMENTSSUSAN G. KOMEN IS A LEADING GLOBAL BREAST CANCER ORGANIZATION, HAVING FUNDED MORE BREAST CANCER RESEARCH THAN ANY OTHER NONPROFIT OUTSIDE THE U.S. GOVERNMENT WHILE PROVIDING REAL TIME HELP TO THOSE FACING THE DISEASE. SINCE ITS FOUNDING IN 1982, KOMEN HAS FUNDED MORE THAN $1 BILLION IN BREAST CANCER RESEARCH AND PROVIDED OVER $2.3 BILLION IN FUNDING FOR PATIENT NAVIGATION, SCREENING, DIAGNOSIS, TREATMENT, EDUCATION, HEALTH SYSTEMS IMPROVEMENT, AND PSYCHOSOCIAL SUPPORT PROGRAMS SERVING MILLIONS OF PEOPLE IN MORE THAN 60 COUNTRIES WORLDWIDE. KOMEN WAS FOUNDED BY NANCY G. BRINKER, WHO PROMISED HER SISTER, SUSAN G. KOMEN, THAT SHE WOULD END THE DISEASE THAT CLAIMED SUZY'S LIFE. RESEARCH SINCE ITS FOUNDING IN 1982, KOMEN'S RESEARCH INVESTMENTS HAVE CONTRIBUTED TO MANY MAJOR ADVANCES IN BREAST CANCER SCIENCE. THE PROGRESS HAS BEEN SIGNIFICANT - TODAY, WE KNOW THAT BREAST CANCER IS MORE THAN A SINGLE DISEASE. WE HAVE A BETTER UNDERSTANDING OF THE GENETICS OF BREAST CANCER AND THE CRITICAL NEED TO TAILOR SCREENING, DIAGNOSIS, TREATMENT, AND PREVENTION STRATEGIES TO INDIVIDUALS THROUGH ADVANCES IN PRECISION MEDICINE. KOMEN'S RESEARCH PROGRAMS ARE FOCUSED ON BREAKTHROUGH RESEARCH TO PREVENT AND CURE BREAST CANCER THROUGH BETTER APPROACHES FOR EARLY DETECTION AND DIAGNOSIS, UNDERSTANDING METASTASIS AND RECURRENCE, AND DEVELOPING NOVEL THERAPIES FOR ALL STAGES OF BREAST CANCER, WITH THE GOAL OF SUPPORTING WORK THAT HAS SIGNIFICANT POTENTIAL TO LEAD TO NEW TREATMENTS AND TECHNOLOGIES THAT WILL REDUCE THE NUMBER OF BREAST CANCER DEATHS IN THE U.S. BY 50 PERCENT BY 2026. KOMEN'S RESEARCH PROGRAMS ARE GUIDED BY 67 OF THE WORLD'S LEADERS IN BREAST CANCER RESEARCH, ONCOLOGY AND ADVOCACY. THE SCIENTIFIC ADVISORY BOARD ASSISTS KOMEN IN SETTING ITS RESEARCH STRATEGY AND PRIORITIZING ITS RESEARCH INVESTMENT. THE KOMEN SCHOLARS LEAD AND PARTICIPATE IN KOMEN'S WORLD-CLASS SCIENTIFIC PEER REVIEW PROCESS. OUR ADVOCATES IN SCIENCE BRING THE COLLECTIVE PATIENT VOICE TO KOMEN'S RESEARCH PROGRAMS AND SCIENTIFIC ACTIVITIES, EMPHASIZING URGENCY AND PATIENT IMPACT. KOMEN AWARDS GRANTS TO INDIVIDUAL SCIENTISTS, RESEARCH TEAMS, AND ORGANIZATIONS AROUND THE WORLD THROUGH A FAIR, TRANSPARENT, RIGOROUS, AND COMPETITIVE REVIEW PROCESS THAT ENSURES MAXIMUM IMPACT FOR OUR RESEARCH INVESTMENT. IN FY19, KOMEN AWARDED 60 GRANTS THROUGH ITS RESEARCH PROGRAMS TO SUPPORT SCIENTIFIC RESEARCH, COLLABORATIONS AND TRAINING IN THE UNITED STATES AND OTHER COUNTRIES, INCLUDING: AUSTRALIA, CANADA, FRANCE, ITALY, AND SOUTH AFRICA. WE HAVE A STRONG COMMITMENT TO SUPPORTING THE NEXT GENERATION OF LEADERS IN BREAST CANCER RESEARCH. SUSTAINING THE WORKFORCE IS CRITICAL; WE WANT TO UNLEASH THEIR CREATIVITY AND INNOVATION TO DRIVE DISCOVERY. THE PUBLIC CANNOT AFFORD TO LOSE PROMISING EARLY CAREER INVESTIGATORS DUE TO A LACK OF FUNDING OPPORTUNITIES. TO THAT END, KOMEN AWARDED CAREER CATALYST RESEARCH GRANTS TO SUPPORT EARLY CAREER INVESTIGATORS IN BREAST CANCER RESEARCH IN THEIR EFFORTS TO CONQUER METASTASIS. KOMEN ALSO AWARDED GRADUATE TRAINING IN DISPARITIES RESEARCH COMPETITIVE RENEWAL GRANTS TO SUPPORT TRAINING LEADERS IN THE FIELD OF BREAST CANCER DISPARITIES RESEARCH. KOMEN ALSO OFFERED LEADERSHIP GRANTS TO SUPPORT KEY WORK BY LEADERS IN THE FIELD OF BREAST CANCER RESEARCH. EACH MECHANISM IS DESCRIBED BELOW. CAREER CATALYST RESEARCH GRANTS (CCR): CCR GRANTS PROVIDE UNIQUE OPPORTUNITIES FOR SCIENTISTS WHO HAVE HELD FACULTY POSITIONS FOR NO MORE THAN 5 YEARS AT THE TIME OF APPLICATION TO ACHIEVE RESEARCH INDEPENDENCE. THE GOAL OF THE FY19 CCR GRANTS IS TO SUPPORT OUTSTANDING TRANSLATIONAL RESEARCH FOCUSED ON THE UNDERSTANDING, DETECTION, AND TREATMENT OF METASTATIC BREAST CANCER WHICH WILL LEAD TO A REDUCTION IN BREAST CANCER DEATHS BY 2026. GRADUATE TRAINING IN DISPARITIES RESEARCH - COMPETITIVE RENEWAL GRANTS (GTDR-CR): GTDR-CR GRANTS PROVIDES FUNDING TO OUTSTANDING PROGRAMS TO ESTABLISH AND/OR SUSTAIN INNOVATIVE TRAINING PROGRAMS FOR GRADUATE STUDENTS SEEKING CAREERS DEDICATED TO ACHIEVING HEALTH EQUITY. THE GOAL OF THE FY19 COMPETITIVE RENEWAL IS TO SUPPORT PROGRAMS FOR AN ADDITIONAL YEAR TO MAINTAIN SUCCESSFUL PROGRAMS THAT ARE WORKING TOWARDS ACHIEVING KOMEN'S BOLD GOAL. LEADERSHIP GRANTS: LEADERSHIP GRANTS PROVIDE SUPPORT FOR HYPOTHESIS-DRIVEN RESEARCH PROJECTS CONDUCTED BY THE DISTINGUISHED BREAST CANCER RESEARCHERS AND CLINICIANS WHO SERVE AS KOMEN'S SCIENTIFIC ADVISORS AND SEEK TO DISCOVER AND DELIVER THE CURES FOR BREAST CANCER. OPPORTUNITY GRANTS / STRATEGIC PARTNERSHIP AND PROGRAM GRANTS (OG/SPP): OG AND SPP GRANTS SUPPORT SPECIAL RESEARCH PROJECTS, PROGRAMS, AND COLLABORATIONS THAT LEVERAGE RESEARCH AND COMMUNITY RESOURCES TO FACILITATE THE DEVELOPMENT OF THE INFRASTRUCTURE, TOOLS, AND OTHER MEANS TO ACCELERATE THE TRANSLATION OF SCIENTIFIC DISCOVERIES FROM BENCH TO BEDSIDE TO CURBSIDE. FUNDING FROM ORGANIZATIONS LIKE KOMEN AND ITS SUPPORTERS HAS PROVEN CRITICAL FOR ALL THESE ACTIVITIES, PARTICULARLY FOR CANCER RESEARCH AND FOR CLINICAL TRIALS. KOMEN'S RESEARCH INVESTMENT THROUGH THESE GRANT MECHANISMS SUPPORTS PROJECTS THAT AIM TO, AMONG OTHER THINGS: (A) DEVELOP NOVEL TREATMENT STRATEGIES FOR METASTATIC DISEASE; (B) CREATE NEW STRATEGIES TO DETECT AND PREVENT RECURRENCE; (C) OVERCOME TREATMENT RESISTANCE; (D) UNDERSTAND AND ADDRESS DISPARITIES IN OUTCOMES; (E) ACCELERATE MEDICAL DISCOVERY AND DELIVERY USING DATA SCIENCE; AND (F) BUILDING ESSENTIAL TOOLS AND RESOURCES TO DRIVE SCIENTIFIC DISCOVERY. EXAMPLES OF RESEARCH GRANTS AWARDED IN FY19 INCLUDE: (A) DEVELOP NOVEL TREATMENT STRATEGIES FOR METASTATIC BREAST CANCER: JOE GRAY, PH.D., OF OREGON HEALTH & SCIENCE UNIVERSITY, WAS AWARDED A LEADERSHIP GRANT TO IMPROVE THE TREATMENT OF HORMONE RECEPTOR POSITIVE METASTATIC BREAST CANCER. HE WILL IDENTIFY FDA-APPROVED DRUGS THAT COULD INCREASE THE EFFICACY OF IMMUNE THERAPIES AND THEN TEST THOSE DRUGS IN PRECLINICAL MODELS. THE GOAL OF THIS STUDY IS TO BETTER INFORM THERAPEUTIC STRATEGIES FOR THESE PATIENTS BY ENHANCING THE IMMUNE SYSTEM'S ABILITY TO KILL THE CANCER CELLS.
(B) CREATE NEW STRATEGIES TO DETECT AND PREVENT RECURRENCEERIC WINER, M.D., OF DANA-FARBER CANCER INSTITUTE, WAS AWARDED A LEADERSHIP GRANT TO IDENTIFY NEW RISK FACTORS OF LATE RECURRENCE OF ESTROGEN RECEPTOR-POSITIVE (ER+) BREAST CANCER. DR. WINER WILL EXAMINE THE IMPACT OF RISK FACTORS SUCH AS BMI, POST-DIAGNOSIS WEIGHT GAIN, POST-DIAGNOSIS PHYSICAL ACTIVITY, AND DIET ON LATE RECURRENCE AND IDENTIFY POTENTIAL THERAPEUTIC INTERVENTIONS. (C) OVERCOME TREATMENT RESISTANCE: AKI MORIKAWA, M.D., PH.D, OF UNIVERSITY OF MICHIGAN, WAS AWARDED A CAREER CATALYST RESEARCH GRANT TO STUDY WAYS TO IMPROVE TREATMENT RESPONSE FOR BREAST CANCER PATIENTS THAT HAVE DEVELOPED BRAIN METASTASES. DR. MORIKAWA WILL TEST THE EFFECTIVENESS OF A LARGE PANEL OF DRUGS ON BRAIN METASTASES SAMPLES FROM PATIENTS. THE GOAL IS TO DETERMINE IF REAL-TIME DRUG TESTING CAN GUIDE TREATMENT DECISIONS IN THE CLINIC AND IMPROVE OUTCOMES FOR BREAST CANCER PATIENTS WHO DEVELOP BRAIN METASTASES. (D) UNDERSTAND AND ADDRESS DISPARITIES IN OUTCOMES: LAUREN MCCULLOUGH, PH.D., OF EMORY UNIVERSITY, WAS AWARDED A CAREER CATALYST RESEARCH GRANT TO IDENTIFY CONTRIBUTORS TO POOR OUTCOMES IN A LARGE DIVERSE POPULATION IN GEORGIA, INCLUDING SOCIOECONOMIC FACTORS, URBAN/RURAL BARRIERS AND RACIAL/ETHNIC FACTORS WHICH CAN ALL LEAD TO DIFFERENCES IN BREAST CANCER METASTASIS OUTCOMES. HER TEAM WILL WORK TO UNDERSTAND WHY THESE DISPARITIES EXIST AND INFORM FUTURE THERAPEUTIC, BEHAVIORAL AND POLICY INTERVENTIONS TO IMPROVE OUTCOMES IN MARGINALIZED POPULATIONS. MELINA ARNOLD, PH.D., OF THE INTERNATIONAL AGENCY FOR RESEARCH ON CANCER, WAS AWARDED A CAREER CATALYST RESEARCH GRANT TO CONDUCT THE FIRST INTERNATIONAL STUDY TO DETERMINE THE TRUE BURDEN OF METASTATIC BREAST CANCER AMONG HIGH-INCOME COUNTRIES. USING POPULATION-BASED DATA AND CANCER REGISTRIES, DR. ARNOLD WILL DETERMINE IF THERE ARE DIFFERENCES IN SURVIVAL OF WOMEN WITH METASTATIC BREAST CANCER ACROSS COUNTRIES AND IDENTIFY FACTORS THAT CONTRIBUTE TO DIFFERENCES IN OUTCOMES. THIS INFORMATION WILL BE USED TO CREATE RECOMMENDATIONS TO HELP ADDRESS METASTATIC BREAST CANCER DISPARITIES AND IMPROVE OUTCOMES. (E) ACCELERATE MEDICAL DISCOVERY AND DELIVERY USING DATA SCIENCE: REGINA BARZILAY, PH.D., OF THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY, WAS AWARDED A LEADERSHIP GRANT TO DEVELOP AN ACCURATE RISK ASSESSMENT MODEL TO PREDICT PATIENTS AT HIGH RISK OF DEVELOPING PRIMARY BREAST CANCER. DR. BARZILAY WILL USE A LARGE COLLECTION OF PATIENTS' MAMMOGRAPH IMAGES WITH KNOWN OUTCOMES TO TEACH MACHINES (ARTIFICIAL INTELLIGENCE) TO IDENTIFY FEATURES THAT PREDICT BREAST CANCER RISK. OVERALL, THE GOAL OF THIS PROJECT IS TO IMPROVE EARLY DETECTION OF BREAST CANCER BY IDENTIFYING WOMEN AT HIGH RISK WHO MIGHT BENEFIT FROM A MORE PERSONALIZED BREAST CANCER SCREENING PROGRAM. MIA LEVY, M.D., OF RUSH UNIVERSITY MEDICAL CENTER WAS AWARDED A LEADERSHIP GRANT TO DEVELOP NOVEL DOCUMENTATION AND REPORTING STRATEGIES WITHIN THE PATIENT ELECTRONIC HEALTH RECORD THAT WOULD ALLOW FOR COLLECTION AND REPORTING OF OUTCOMES RELATED TO THE MANAGEMENT OF ADJUVANT ENDOCRINE THERAPY (AET), DEFINED AS LEARNING HEALTHCARE SYSTEM (LHS). THE ULTIMATE GOAL OF THIS STUDY IS TO IMPLEMENT THE LHS AND CHANGE HEALTHCARE DELIVERY FOR PATIENTS WITH BREAST CANCER, DECREASING RATES OF RECURRENCE AND DEATH FROM BREAST CANCER. (F) BUILDING ESSENTIAL TOOLS AND RESOURCES TO DRIVE SCIENTIFIC DISCOVERY JOHNS HOPKINS UNIVERSITY WAS AWARDED A SPONSORED PROGRAMS GRANT TO SUPPORT THE TRANSLATIONAL BREAST CANCER RESEARCH CONSORTIUM (TBCRC). THE TBCRC IS A COLLABORATION OF 19 CLINICAL SITES THAT WORK TOGETHER TO CONDUCT INNOVATIVE, HIGH-IMPACT, BIOLOGICALLY-DRIVEN TRANSLATIONAL AND CLINICAL RESEARCH TO IMPROVE OUTCOMES FOR BREAST CANCER PATIENTS. SINCE 2006, THE TBCRC HAS DEVELOPED 50 CLINICAL TRIALS, ABOUT HALF OF WHICH HAVE FOCUSED ON METASTATIC BREAST CANCER, DRUG RESISTANCE AND/OR RECURRENCE. TBCRC FINDINGS HAVE BEEN REPORTED IN OVER 80 SCIENTIFIC PEER REVIEWED PUBLICATIONS AND PRESENTATIONS TO DATE, INCLUDING 8 JOURNAL ARTICLES, AND 10 POSTER PRESENTATIONS, 3 POSTER DISCUSSIONS AND 1 TALK AT SCIENTIFIC CONFERENCES IN FY19. THE SUSAN G. KOMEN TISSUE BANK AT THE INDIANA UNIVERSITY SIMON CANCER CENTER (KTB), WAS AWARDED A SPONSORED PROGRAMS GRANT TO SUPPORT THE WORLD'S ONLY BIOREPOSITORY OF HEALTHY BREAST TISSUE. THE KTB COLLECTS AND STORES HEALTHY TISSUE AND BLOOD SAMPLES FROM DIVERSE POPULATIONS OF WOMEN REPRESENTING THE ENTIRE CONTINUUM OF BREAST DEVELOPMENT FROM PUBERTY TO MENOPAUSE. THE SAMPLES CAN BE UTILIZED BY RESEARCHERS WORLDWIDE TO STUDY BREAST ONCOGENESIS (WHEN CANCER FORMS AND NORMAL CELLS ARE TRANSFORMED INTO CANCER CELLS). SINCE ITS FOUNDING IN 2007, THE KTB HAS COLLECTED BREAST TISSUE SPECIMENS FROM MORE THAN 5,000 HEALTHY DONORS AND BLOOD FROM OVER 11,000 INDIVIDUALS. TO DATE, KTB'S RESOURCES HAVE LED TO 44 SCIENTIFIC PEER REVIEWED PUBLICATIONS, INCLUDING 5 JOURNAL ARTICLES IN FY19. EDUCATION AND PATIENT SUPPORT: KOMEN IS A TRUSTED SOURCE OF BREAST CANCER INFORMATION FOR PEOPLE ALL OVER THE WORLD AND IS INSTRUMENTAL IN CONNECTING PEOPLE WITH THE RESOURCES THEY NEED IN THEIR FIGHT AGAINST BREAST CANCER. OUR WEBSITE, KOMEN.ORG, PROVIDES CURRENT, SAFE, ACCURATE, COMPREHENSIVE, AND UNBIASED INFORMATION ABOUT BREAST CANCER, BASED ON SCIENTIFIC EVIDENCE. CONTENT IS OFFERED IN A VARIETY OF FORMATS INCLUDING INTERACTIVE VIDEO USING ANIMATION AND VOICEOVER IN ENGLISH AND SPANISH, ILLUSTRATIONS, CHARTS, GRAPHS, AND SHORT VIDEOS TO MEET THE LEARNING PREFERENCES AND NEEDS OF OUR WEB VISITORS. THE "ABOUT BREAST CANCER" SECTION OF KOMEN'S WEBSITE, CO-DEVELOPED WITH HARVARD MEDICAL SCHOOL FACULTY AND DANA-FARBER/BRIGHAM AND WOMEN'S CANCER CENTER STAFF, RECEIVED MORE THAN 5.5 MILLION PAGE VIEWS DURING FY19. KOMEN ALSO PROVIDES EVIDENCE-BASED, EASY-TO-READ EDUCATIONAL MATERIALS IN DOWNLOADABLE FORMATS ON KOMEN.ORG. EXAMPLES OF KOMEN EDUCATIONAL MATERIALS INCLUDE: A) BREAST SELF-AWARENESS MESSAGE CARDS IN MORE THAN 40 LANGUAGES, B) BREAST CANCER SPECIFIC BROCHURES AND FACTSHEETS, C) BOOKLETS WITH SUPPORT INFORMATION FOR SURVIVORS AND CO-SURVIVORS, AND D) TOOLKITS FOR BREAST CANCER OUTREACH AND EDUCATION FOR HISPANIC/LATINO IN ENGLISH AND SPANISH AND FOR BLACK AND AFRICAN-AMERICAN COMMUNITIES. THE SUSAN G. KOMEN "1-877 GO KOMEN" (1-877-465-6636) BREAST CARE HELPLINE OFFERS BREAST CANCER EDUCATION, PSYCHOSOCIAL SUPPORT, AND INFORMATION ABOUT COMMUNITY RESOURCES FOR PATIENTS, FAMILIES, AND FRIENDS. THE CLINICAL TRIAL INFORMATION HELPLINE PROVIDES INFORMATION, RESOURCES, COACHING AND SUPPORT RELATED TO BREAST CANCER CLINICAL TRIALS. THE HELPLINE OPERATES FROM 9 A.M. - 10 P.M. E.T. THE SERVICE IS OFFERED IN ENGLISH, SPANISH, AND TAGALOG. DURING FY19, THE KOMEN HELPLINE RESPONDED TO MORE THAN 15,000 CALLS AND EMAILS. IN ADDITION, IN FY19 KOMEN PARTNERED WITH LIVING BEYOND BREAST CANCER TO DEVELOP AND DELIVER A CONFERENCE FOR WOMEN LIVING WITH METASTATIC BREAST CANCER IN THE WASHINGTON, D.C. REGION. THE CONFERENCE BRINGS PEOPLE WITH METASTATIC BREAST CANCER, CAREGIVERS, HEALTHCARE PROFESSIONALS, HEALTHCARE ORGANIZATIONS, SUPPORT ORGANIZATIONS AND OTHERS, WHO PARTICIPATE IN THE CARE OF PATIENTS WITH METASTATIC BREAST CANCER, TO DISCUSS SCIENTIFIC BREAKTHROUGHS, ONGOING CLINICAL TRIALS, QUALITY OF LIFE, AND INTEGRATIVE MEDICINE. THE CONFERENCE IS DESIGNED TO FILL THE NEEDS OF THE METASTATIC BREAST CANCER COMMUNITY AND SEEKS TO STRENGTHEN METASTATIC BREAST CANCER VOICES IN THE NATIONAL CAPITAL REGION BY CREATING OPPORTUNITIES FOR LEARNING, ENGAGEMENT AND ACTION. BREAST CANCER IS THE MOST COMMON CANCER IN WOMEN, WORLDWIDE, AND THE NUMBER OF CASES IS INCREASING IN NEARLY EVERY COUNTRY. THE NUMBER OF NEW BREAST CANCER CASES HAS MORE THAN DOUBLED AROUND THE WORLD IN THE LAST THREE DECADES, WITH HIGHEST INCREASES OBSERVED IN LOW- AND MIDDLE-INCOME COUNTRIES. THESE TRENDS ARE CONCERNING, WHICH IS WHY KOMEN WORKS TIRELESSLY TO PROVIDE SUPPORT TO BREAST HEALTH PROGRAMS WORLDWIDE. IT TAKES COLLABORATION AND STRONG PARTNERSHIPS TO MAKE A GLOBAL IMPACT. KOMEN STRIVES TO SERVE AS A "BRIDGE" - COLLABORATING WITH INTERNATIONAL NONPROFITS, CORPORATIONS, AND MINISTRIES OF HEALTH TO BRING TOGETHER PEOPLE AND ORGANIZATIONS TO DEVELOP PROGRAMS THAT ARE TAILORED TO THE SPECIFIC NEEDS OF THE COMMUNITY AND SENSITIVE TO CULTURAL DIFFERENCES. IN FY19, KOMEN'S GLOBAL PROGRAM AWARDED TEN GRANTS TO SUPPORT EDUCATION PROGRAMMING FOR PATIENTS AND FOR HEALTH PROFESSIONALS AND TO REDUCE BARRIERS TO BREAST CANCER CARE IN CHINA, COLOMBIA, MEXICO, PANAMA, AND ZAMBIA.
PUBLIC POLICY AND ADVOCACYSUSAN G. KOMEN IS COMMITTED TO DOING EVERYTHING WE CAN TO SERVE MORE THAN 260,000 WOMEN AND MEN IN THE UNITED STATES WHO WILL BE DIAGNOSED WITH BREAST CANCER THIS YEAR, THE MORE THAN 150,000 WHO ARE CURRENTLY LIVING WITH INCURABLE BREAST CANCER, AND TO SAVE THE MORE THAN 42,000 WOMEN AND MEN WHO WILL LOSE THEIR LIVES IN 2019. THIS INCLUDES MOBILIZING THE VOICE OF EVERYONE IMPACTED BY THE DISEASE TO IMPROVE OUTCOMES AND SAVE LIVES THROUGH SOUND PUBLIC POLICY. ONLY THROUGH INFORMED GOVERNMENT ACTION CAN WE MAKE THE BROAD, SYSTEMIC AND LASTING CHANGE WE NEED TO HELP US ACHIEVE OUR BOLD GOAL OF REDUCING THE CURRENT NUMBER OF BREAST CANCER DEATHS BY 50% IN THE U.S. BY 2026. KOMEN WORKS TO ENSURE THAT THE FIGHT AGAINST BREAST CANCER IS A PRIORITY AMONG POLICYMAKERS IN WASHINGTON, D.C., AND EVERY STATE CAPITOL ACROSS THE COUNTRY. EVERY TWO YEARS, THROUGH A TRANSPARENT, BROAD-BASED AND INTENSIVE VETTING AND SELECTION PROCESS, KOMEN WORKS TO IDENTIFY THE POLICY ISSUES WITH THE GREATEST POTENTIAL MISSION IMPACT. THIS PROCESS INCLUDES COLLECTING FEEDBACK FROM KOMEN AFFILIATES FROM ACROSS THE COUNTRY; ADVISORY GROUPS INCLUDING ADVOCATES IN SCIENCE (AIS) AND KOMEN SCHOLARS; REPRESENTATIVES FROM THE METASTATIC BREAST CANCER COMMUNITY AND KOMEN'S AFRICAN AMERICAN HEALTH EQUITY INITIATIVE; AND OTHER STAKEHOLDERS WITH A VESTED INTEREST IN BREAST CANCER-RELATED ISSUES. THE SELECTED ISSUES ARE THE BASIS FOR KOMEN'S STATE AND FEDERAL ADVOCACY. KOMEN'S 2018-2019 ADVOCACY PRIORITIES INCLUDED: SUPPORTING EXPANDED FEDERAL FUNDING FOR BREAST CANCER RESEARCH AT THE NATIONAL INSTITUTES OF HEALTH (NIH) AND THE DEPARTMENT OF DEFENSE (DOD); SUPPORTING STATE AND FEDERAL FUNDING FOR THE CENTERS FOR DISEASE CONTROL AND PREVENTION'S (CDC) NATIONAL BREAST AND CERVICAL CANCER EARLY DETECTION PROGRAM (NBCCEDP); ADVOCATING FOR STATE AND FEDERAL POLICIES TO IMPROVE INSURANCE COVERAGE OF BREAST CANCER TREATMENTS, INCLUDING THOSE THAT WOULD REQUIRE ORAL PARITY, PRECLUDE SPECIALTY TIERS AND PREVENT STEP THERAPY PROTOCOLS; ADVOCATING FOR STATE AND FEDERAL POLICIES TO REDUCE OR ELIMINATE OUT-OF-POCKET COSTS FOR MEDICALLY NECESSARY DIAGNOSTIC IMAGING; AND EVALUATING STATE AND FEDERAL POLICIES TO INCREASE PUBLIC ACCESS TO INFORMATION ABOUT AND PARTICIPATION IN CLINICAL TRIALS FOR ALL PATIENT POPULATIONS. IN ADDITION TO THE STATE AND FEDERAL WORK ON OUR 2018-2019 ADVOCACY PRIORITIES, KOMEN CONTINUED OUR EFFORTS TO ENSURE EVERY BREAST CANCER PATIENT AND SURVIVOR HAS ACCESS TO AFFORDABLE, QUALITY HEALTH INSURANCE AND CARE. KOMEN ALSO ENGAGED ON ISSUES RELATED TO BREAST DENSITY, COMPASSIONATE USE, GENETIC TESTING, LYMPHEDEMA, PALLIATIVE CARE AND SURVIVORSHIP. KOMEN DEVELOPED AND IMPLEMENTED ADVOCACY CAMPAIGNS TO ENCOURAGE LAWMAKERS AND AGENCY OFFICIALS TO SUPPORT AND IMPLEMENT PROGRAMS THAT WOULD ADVANCE OUR PRIORITY ISSUES AND ADDITIONAL POLICY AREAS TO ACHIEVE KOMEN'S BOLD GOAL. KOMEN CONTINUED TO RECRUIT AND ENGAGE ADVOCATES TO FURTHER STRENGTHEN ITS GRASSROOTS ADVOCACY NETWORK. SCREENING AND PATIENT NAVIGATION GETTING REGULAR SCREENING TESTS, ALONG WITH EFFECTIVE AND QUALITY TREATMENT IF DIAGNOSED, LOWERS THE RISK OF DYING FROM BREAST CANCER. SCREENING TESTS CAN FIND BREAST CANCER EARLY, WHEN CHANCES FOR SURVIVAL ARE HIGHEST. PATIENT NAVIGATION IS A PROCESS BY WHICH AN INDIVIDUAL - A PATIENT NAVIGATOR - GUIDES PATIENTS THROUGH AND AROUND BARRIERS IN THE COMPLEX CANCER CARE SYSTEM. EVIDENCE SHOWS NAVIGATION IMPROVES ADHERENCE TO SCREENING RECOMMENDATIONS, AND THUS IMPROVES OVERALL OUTCOMES. KOMEN SUPPORTS FREE AND LOW-COST SCREENING PROGRAMS IN UNDERSERVED COMMUNITIES THAT HELP NAVIGATE PEOPLE TO QUALITY CARE, AND/OR PROVIDE COVERAGE FOR SCREENING SERVICES TO PEOPLE WITHOUT HEALTH INSURANCE, OR THOSE WITH HIGH CO-PAYS AND DEDUCTIBLES THAT MAKE SCREENING TOO COSTLY. IN FY19, KOMEN AWARDED ONE SCREENING COMMUNITY GRANT TO BREAST CARE FOR WASHINGTON, TO DEVELOP A MOBILE MAMMOGRAPHY PROJECT TO INCREASE ACCESS TO QUALITY SCREENING AND NAVIGATE WOMEN INTO DIAGNOSIS AND TREATMENT. TREATMENT AND PATIENT NAVIGATION BARRIERS TO QUALITY CARE ARE OFTEN ASSOCIATED WITH POOR BREAST CANCER OUTCOMES AND RESULTANT CANCER DISPARITIES AMONG SPECIFIC POPULATION GROUPS. ACCORDING TO QUALITATIVE DATA COLLECTED FROM ACROSS KOMEN'S AFFILIATE NETWORK, THE MOST COMMON BARRIERS TO QUALITY CARE IN THE UNITED STATES INCLUDE: (1) AVAILABILITY OF LOCAL SERVICES; (2) BREAST CANCER EDUCATION; (3) CULTURAL/LANGUAGE; (4) FEAR; (5) FINANCIAL; (6) INSURANCE; (7) TRANSPORTATION. PATIENT NAVIGATION IS A PROCESS BY WHICH AN INDIVIDUAL - A PATIENT NAVIGATOR - GUIDES PATIENTS THROUGH AND AROUND BARRIERS IN THE COMPLEX CANCER CARE SYSTEM TO ENSURE TIMELY DIAGNOSIS AND TREATMENT. EVIDENCE SHOWS PATIENT NAVIGATION IMPROVES ADHERENCE TO TREATMENT RECOMMENDATIONS, RESULTING IN IMPROVED OUTCOMES. IN FY19, KOMEN FUNDED THREE NONPROFIT ORGANIZATIONS IN SUPPORT OF PROGRAMS TO REDUCE STRUCTURAL, PERSONAL, SOCIOCULTURAL, AND FINANCIAL BARRIERS TO CARE, AND PROVIDE PATIENT NAVIGATION SERVICES FOR UNDERSERVED COMMUNITIES IN THE WASHINGTON, D.C. METRO AREA, SPECIFICALLY WARDS 2, 5, 7, AND 8, AND ALEXANDRIA CITY, VA. KOMEN'S TREATMENT ASSISTANCE PROGRAM, ADMINISTERED BY CANCERCARE, AIMS TO HELP WOMEN AND MEN IN BREAST CANCER TREATMENT WHO ARE FACING FINANCIAL CHALLENGES STAY IN TREATMENT BY PROVIDING LIMITED FINANCIAL ASSISTANCE, EDUCATION, AND SUPPORT SERVICES. FINANCIAL ASSISTANCE IS GRANTED TO UNDERSERVED, UNDERINSURED OR UNINSURED WOMEN AND MEN ACROSS THE COUNTRY UNDERGOING BREAST CANCER TREATMENT WHO MEET PRE-DETERMINED ELIGIBILITY CRITERIA. THIS PROGRAM PROVIDES FINANCIAL ASSISTANCE FOR TREATMENT-RELATED COSTS, INCLUDING TRANSPORTATION TO AND FROM TREATMENT, CHILD/ELDER CARE, HOME CARE, ORAL PAIN/ANTI-NAUSEA MEDICATIONS, ORAL CHEMOTHERAPY/HORMONE THERAPY, LYMPHEDEMA CARE/SUPPLIES, PALLIATIVE CARE, AND DURABLE MEDICAL EQUIPMENT. WE SERVED MORE THAN 3500 PEOPLE THROUGH THIS PROGRAM IN FY19.
EXECUTIVE COMMITTEEFORM 990, PART VI, LINE 1A THE ORGANIZATION'S BYLAWS PROVIDE FOR AN EXECUTIVE COMMITTEE COMPRISED OF A MINIMUM OF FIVE MEMBERS INCLUDING THE BOARD CHAIR, THE PRESIDENT AND CHIEF EXECUTIVE OFFICER, AND ADDITIONAL BOARD MEMBERS, AS RECOMMENDED BY THE GOVERNANCE COMMITTEE AND APPOINTED BY THE BOARD OF DIRECTORS. MEMBERS OF THE EXECUTIVE COMMITTEE MUST EITHER BE DIRECTORS OF THE ORGANIZATION OR THE PRESIDENT AND CHIEF EXECUTIVE OFFICER. THE BYLAWS PROVIDE THE EXECUTIVE COMMITTEE WITH THE AUTHORITY TO: (A) APPOINT MEMBERS TO NON-STANDING COMMITTEES OF THE ORGANIZATION, AND NAME CHAIRS OF SUCH COMMITTEES; (B) AUTHORIZE UNBUDGETED DISBURSEMENTS BY THE ORGANIZATION IN ACCORDANCE WITH THE SPECIFIC EXPENDITURE AUTHORITY PRESCRIBED BY THE BOARD OF DIRECTORS; (C) EMPLOY AGENTS; AND (D) CARRY INTO EXECUTION SUCH OTHER MEASURES AS IT DETERMINES WILL PROMOTE THE PURPOSE OF THE ORGANIZATION. THE COMMITTEE ALSO MAY EXERCISE, WHEN THE BOARD IS NOT IN SESSION, ALL OF THE AUTHORITY OF THE BOARD IN THE MANAGEMENT OF THE BUSINESS AND AFFAIRS OF THE ORGANIZATION WITH CERTAIN EXCEPTIONS SUCH AS REPEALING ANY BOARD RESOLUTIONS, AMENDING THE ORGANIZATION'S ARTICLES OR BYLAWS, OR MERGING OR DISSOLVING THE ORGANIZATION. THIS DELEGATION DOES NOT RELIEVE THE BOARD OF ANY OF ITS RESPONSIBILITIES IMPOSED BY LAW, AND THE COMMITTEE ENDEAVORS TO LIMIT ITS EXERCISE OF AUTHORITY TO TIME SENSITIVE ISSUES.
DESCRIBE THE PROCESS USED BY MANAGEMENT AND/OR GOVERNING BODY TOREVIEW 990 FORM 990, PART VI, QUESTION 11B MANAGEMENT PREPARES THE MATERIALS FOR THE FORM 990, WITH THE ASSISTANCE OF AND REVIEW BY EXTERNAL ACCOUNTANTS. SENIOR LEVEL MANAGEMENT REVIEW AND COMMENT ON THE FINAL DRAFT OF THE FORM 990 FOR SUBSEQUENT PRESENTATION TO THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS. THE AUDIT COMMITTEE REVIEWS, MAKES RECOMMENDATIONS, AND APPROVES THE FORM 990 FOR PRESENTATION TO THE BOARD OF DIRECTORS. THEREAFTER, THE BOARD OF DIRECTORS REVIEWS AND APPROVES THE FORM 990 PRIOR TO FILING.
DESCRIPTION OF PROCESS TO MONITOR TRANSACTIONS FOR CONFLICTS OF INTERESTFORM 990, PART VI, QUESTION 12C Komen's Conflict of Interest Policy requires every board member, officer, committee member, advisory board member, and employee to avoid conflicts of Interest. It also requires these persons to report any actual and/or potential conflicts of interest as soon as possible. Reports are reviewed by the General Counsel's office and/or Internal Audit, and appropriate action is taken pursuant to the Conflict of Interest Policy. Further, Komen produces an annual survey requiring all board members, officers, committee members, advisory board members, and employees to review the Conflict of Interest Policy and disclose any additional actual/potential conflicts of interest. These annual disclosures are reviewed in the same manner. The Audit Committee of the Board of Directors receives, and reviews all reported actual and potential conflicts of interest and the related action to address them.
OFFICES & POSITIONS FOR WHICH PROCESS WAS USED, & YEAR PROCESS WAS BEGUNFORM 990, PART VI, QUESTION 15A & 15B THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS ASSISTS THE BOARD IN OVERSEEING COMPENSATION POLICIES AND BEST PRACTICES. RESPONSIBILITIES INCLUDE OVERSIGHT OF THE COMPENSATION OF THE CHIEF EXECUTIVE OFFICER; THE RANGE OF COMPENSATION LEVELS FOR THE ORGANIZATION'S OTHER OFFICERS, DISQUALIFIED PERSONS, AND OTHER KEY EMPLOYEES; GRANTING THE CHIEF EXECUTIVE OFFICER WITH THE AUTHORITY TO DETERMINE COMPENSATION LEVELS WITHIN AN APPROVED RANGE; AND ANY INCENTIVE/BONUS COMPENSATION PROGRAMS, IF APPROVED. THE CURRENT POLICY WAS ADOPTED IN 2010. A FORMAL COMPENSATION POLICY GOVERNS PAY PRACTICES. PERIODICALLY, ALL POSITIONS IN THE ORGANIZATION ARE REVIEWED AGAINST EXTERNAL MARKET DATA BY ENGAGING INDEPENDENT EXPERTS OR ACQUIRING UPDATED MARKET DATA TO CONDUCT THE BENCHMARKING PROCESS. COMPENSATION IS THEN BASED UPON COMPARABLE MARKET RATES OF PAY WITH CONSIDERATION FOR INTERNAL EQUITY AND THE FINANCIAL POSITION OF THE ORGANIZATION. BENCHMARKING WAS CONDUCTED FOR THE CHIEF EXECUTIVE OFFICER AND ALL EXECUTIVE TEAM MEMBERS' COMPENSATION TO EXTERNAL MARKET DATA IN 2019, TO ENSURE MARKET ALIGNMENT. KOMEN PROVIDES SALARY INCREASES, PROMOTIONS AND OTHER FORMS OF COMPENSATION WITHOUT REGARD TO RACE, COLOR, RELIGION, GENDER, NATIONAL ORIGIN, DISABILITY, VETERAN STATUS OR SEXUAL ORIENTATION.
AVAIL OF GOV DOCS, CONFLICT OF INTEREST POLICY, & FIN STMTS TO GEN PUBLICFORM 990, PART VI, QUESTION 19 KOMEN'S FINANCIAL STATEMENTS AND THE FORM 990 ARE PUBLICLY AVAILABLE ON OUR WEBSITE. THE CERTIFICATE OF FORMATION IS AVAILABLE FROM THE TEXAS SECRETARY OF STATE AND OTHER GOVERNING DOCUMENTS ARE MADE AVAILABLE AS REQUIRED BY STATE LAW. FORM 1023 AND THE CONFLICT OF INTEREST POLICY ARE NOT PUBLISHED ONLINE BUT ARE AVAILABLE TO THE PUBLIC UPON REQUEST.
ADDITIONAL DETAIL ON EVENT PRODUCTION EXPENSES INCLUDED ON OTHER EXPFORM 990, PART IX, LINE 24 KOMEN PAYS 50% OF THE COST OF ALL T-SHIRTS FOR THE 111 SUSAN G. KOMEN RACE FOR THE CURE AND MORE THAN PINK WALK EVENTS CONDUCTED BY THE KOMEN AFFILIATES DURING THE FISCAL YEAR. ACCOUNTS RECEIVABLE FORM 990, PART X, LINE 4 The beginning of year amount for accounts receivable was determined by adding the amount of accounts receivable with pledges and grants receivable, net (line 3A).
OTHER CHANGES IN NET ASSETS OR FUND BALANCESFORM 990, PART XI, LINE 9 RESCINDED GRANTS $1,681,546 UTAH FIELD OFFICE ADJUSTMENT $717 ----------------- TOTAL $1,682,263 ==========